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Abstract 
Hydrogen sulfide (H2S) has emerged as a novel and important gasotransmitter for the 
cardiovascular system, where it is generated mainly by cystathionine γ-lyase (CSE). Abnormal 
metabolism and functions of the H2S/CSE pathway have been linked to cardiovascular diseases 
including hypertension and atherosclerosis. Hypoxic stress is a hallmark of these 
pathophysiological processes. Here we characterized the response of vascular smooth muscle 
cells (SMCs) derived from CSE-knockout (KO) mice to hypoxic stress. Under basal conditions 
we found that KO cells exhibited increased metabolic activity (+27 %), ROS levels (+127 %) and 
mitochondrial membrane potential (Ψm) (+62 %) than their wild-type (WT) counterparts. These 
data suggest an impaired ability of KO cells to regulate redox levels and/or increased by-
production of ROS resulting from deficient H2S-mediated regulation of mitochondrial activity in 
the KO cells. Hypoxic insult (12 h, 1 % O2) caused a decrease (-61 %) in KO cell metabolism and 
a dramatic increase in apoptosis of KO versus WT cells (+85 % versus +23 %), indicating 
susceptibility of KO SMCs to hypoxic stress. We also found hypoxia-induced increases in the 
activity of antioxidant enzyme, superoxide dismutase, in both WT and KO cells, but markedly 
increased (+75 %) ROS levels in hypoxic KO cells, revealing a profound redox imbalance 
therein. Additionally, we noted: (i) a large Ψm increase (+118 %) in hypoxic KO versus WT cells; 
(ii) that KO SMCs featured altered inflammatory mediator expression both under basal and 
hypoxic conditions; (iii) blunted hypoxia inducible factor-1α expression in the CSE-deficient 
cells. Taken together, these data demonstrate that H2S/CSE pathway is essential for SMC survival 
under hypoxic conditions, and suggest that endogenous H2S modulates redox and inflammatory 
status and mitochondrial activity, deficiency of which may cause the observed vulnerability of 
KO cells to hypoxia.  
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In another series of experiments, we examined the effect of the hypoxia mimetic, cobalt 
chloride (CoCl2), as well as hypoxia-reoxygenation (H-R) stress, on HL-1 murine 
cardiomyocytes. We demonstrated that both CoCl2 and H-R caused decreased cardiomyocyte 
viability (-28 % and -37 %, respectively), and that CSE expression was concomitantly increased 
(+79 % and +94 %, respectively). D-propargylglycine-mediated inhibition of CSE was found to 
exacerbate CoCl2-induced decreases in cardiomyocyte viability. Taken together, these data 
indicate that H2S/CSE pathway is upregulated in response to both simulated hypoxia and H-R 
stress, and that endogenous H2S/CSE pathway contributes to cardioprotection against CoCl2-
induced stress.  
These findings suggest an important role for endogenous H2S/CSE pathway in 
cytoprotection against hypoxia in murine SMCs, as well as against simulated hypoxia and H-R 
stress in HL-1 murine cardiomyocytes. Moreover, they are consistent with the concept of 
meaningful involvement of H2S/CSE pathway in the hypoxia stress response and the recent 
suggestion of H2S/HIF-1 interaction. 
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Preface 
Deep within the Hadean ocean, the first precursors of modern life may have consisted of a 
simple metabolism upon an iron sulfide surface, driven by its oxidation to pyrite and the 
formation of hydrogen from hydrogen sulfide (H2S) [1]. When the unmanned submarine “Alvin” 
probed the depths of the Pacific Ocean near the Galapagos Islands in 1977, scientists came upon 
hydrothermal vents featuring a unique and previously unknown ecosystem of creatures that had 
developed alone in a harsh and sunless environment. The hot, metal sulfide-rich waters were 
enriched with H2S that spilled out of the chimney-like structures, and this was providing a food 
source for these life forms. However, natural gases are not solely an alimentary aspect of 
microbial life; many archaea and bacteria produce large amounts of gas for their own use and for 
the maintenance of their immediate environment. Not unlike these microorganisms, the human 
body also produces many gases, the functions of many of which remain unclear.  
Given H2S’s ancient essential role, one might think it unsurprising that over 3.8 billion 
years later, it appears that H2S is critical to the machinations of human life. But it is surprising, 
for we have, until scantly 10 years ago, known H2S – with its signature odour of rotten eggs – to 
be a notorious environmental and industrial toxicant that is roughly equivalent to cyanide. Still, a 
rich and rapidly growing body of evidence demonstrates that not only is H2S endogenously 
produced within mammalian tissues, but also that it exerts significant physiological effects [2]. 
Thus, there exists a striking parallel: H2S as primordial heart of a chemoautotrophic modality that 
may underlie the origins of life, and H2S’s increasingly clear physiological importance for 
mammalian biological homeostasis. 
At the turn of the century, H2S joined nitric oxide and carbon monoxide as the newest 
member of the new, unique class of gaseous signaling molecules called ‘gasotransmitters’ [3]. 
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Their common defining feature permits them to move through membranes, free of the 
regimented, receptor-dependent movement typical of other signaling transmitters. And while 
functional and mechanistic similarities exist among these gasotransmitters, H2S acts in some 
novel ways, including, for example, inducement of vascular and non-vascular smooth muscle 
relaxation via the direct activation of adenosine triphosphate-sensitive potassium channels [3, 4]. 
Perhaps unsurprising given its mobility, a plethora of other roles for H2S have been discovered in 
wide-ranging biological systems including the cardiovascular, neuronal and gastrointestinal, 
affecting a variety of cell types in a multitude of ways. 
H2S has emerged as an important regulator of cardiovascular homeostasis, playing key 
roles in cardiac function, cell survival, maintenance of mitochondrial structure and function, 
oxidative stress, inflammation, ion channel modulation and metabolism. H2S is cardioprotective 
against ischemia-reperfusion injury, is implicated in the phenomena of ischemic pre- and post-
conditioning, and its biosynthesis is impaired in contributing to atherosclerosis, diabetes and 
hypertension. Recently, an oxygen-sensing role for H2S has also been suggested, which, 
considering its ancient context, further underscores its base centrality to essential cellular 
functions such as metabolism and oxygen handling. Here we have endeavoured to investigate 
H2S’s role in the cellular responses to hypoxia and ‘simulated’ hypoxia (chemical inducement of 
hypoxia-responsive signaling) in two murine cell types, cardiomyocytes and smooth muscle cells. 
We have focused on alteration and measurement of cystathionine γ-lyase, the principal source of 
H2S in cardiovascular tissues. These investigations are timely, relevant, and add new knowledge 
to the explosive, exciting field of gasotransmitter biology.  
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Introduction 
 
“We shall not cease from exploration 
And the end of all our exploring 
Will be to arrive where we started 
And know the place for the first time.” 
 - T. S. Eliot 
 
1 – The arrival of hydrogen sulfide 
Vehicles for intracellular communication fall into two categories: electrical signal via gap 
junction and chemical substances, which include hormones, autocoids and transmitters [5]. Put 
simply, the triggering event for most signal transduction processes is the binding of ligand with 
receptor at the plasma membrane, causing a cascade of intracellular second messengers that relay 
and propagate the extracellular signal and modulate cellular activity [5]. The novel concept of 
endogenous gaseous signaling transmitters or gasotransmitters has been verified in a wide variety 
of biological systems, including the cardiovascular, neuronal and gastrointestinal. Despite their 
common function as signal transducers, these molecules are drastically different from classic 
neurotransmitters and humoral factors – such as acetylcholine, catecholamines, glutamate, and 
adenosine triphosphate (ATP) and its metabolites  – in a number of important ways, including 
[5]:  
1. Neurotransmitters are released via exocytotic vesicles; gasotransmitters are released in the 
cytoplasm.  
2. Neurotransmitters are re-uptaken; gasotransmitters are not. 
3. Neurotransmitter removal is enzyme-dependent; gasotransmitter removal is not. 
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4. Neurotransmitters are unidirectional (pre- to post-synaptic membrane); gasotransmitters 
are bidirectional. 
5. Neurotransmitters are membrane receptor-dependent; gasotransmitters are not.  
Thus, gasotransmitters are starkly distinguished from their signaling forebears and deserving of 
separate treatment. However, given the plethora of gases present in mammalian tissues, ground 
rules for their identification are needed. The following criteria have therefore been suggested for 
the classification of gasotransmitters [3]:  
1. They are small molecules of gas. 
2. They are freely permeable to membranes. As such, their effects do not rely on cognate 
membrane receptors. 
3. They are endogenously and enzymatically generated and their production is regulated. 
4. They have well-defined and specific functions at physiologically relevant concentrations. 
5. Their functions can be mimicked by their exogenously applied counterparts. 
6. Their cellular effects may or may not be mediated by second messengers but should have 
specific cellular and molecular targets. 
To date, it is agreed that nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide 
(H2S) are proven gasotransmitters. Several other gases – including ammonia and acetaldehyde – 
have also been proposed, but a relative paucity of information prevents their classification as yet 
[5]. And while these three gases share common chemical features and biological modes of action, 
important differences exist, particularly in the case of H2S, the most recent arrival on the 
gasotransmitter scene. Chief among their common modalities is the regulation of membrane ion 
channels, either via second messengers or direct interaction with ion channel proteins; a novel 
mechanism that has garnered much interest in far-ranging biomedical fields [5]. These include 
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interactions with calcium-sensitive potassium (KCa), ATP-sensitive potassium (KATP), voltage-
gated Ca2+, voltage-gated Na+ and cyclic nucleotide-gated ion channels, via mechanisms 
including phosphorylation, S-nitrosylation, carboxylation, sulfuration, and altered cellular redox 
status [5]. The following brief overview provides further context on H2S’s gasotransmitter 
forerunners, NO and CO. 
The discovery that NO was the molecule responsible for the majority of the vasorelaxant 
effect of the so-called endothelium-derived relaxing factor led to the journal Science naming it 
the 1992 “Molecule of the Year”. Indeed, the seminal discovery of NO’s signaling properties by 
Ferid Murad, Robert Furchgott and Louis Ignarro earned them the Nobel Prize in Physiology or 
Medicine in 1998. NO is synthesized from L-arginine by nitric oxide synthase (NOS), of which 
there are three isoforms featuring different tissue distribution and functions: endothelial (eNOS), 
neuronal (nNOS) and inducible (iNOS) [6]. Put simply, both eNOS and nNOS are calcium-
dependent enzymes that produce relatively small amounts of NO, while iNOS is calcium-
independent and capable of producing relatively large amounts of NO that often exert toxic 
effects [6]. Each NOS isoform consists of a carboxy-terminal reductase section, an aminoterminal 
oxygenase section and a calmodulin section that is responsible for electron flow from the 
reductase to the oxygenase domain. In general, lower NO concentrations promote cell survival 
and proliferation, whereas higher levels favour cell cycle arrest, apoptosis and senescence [7]. 
The major cell types that produce NO are endothelial cells, neurons, smooth muscle cells (SMCs) 
and macrophages [6]. 
NO acts through several mechanisms, including oxidation of heme proteins, activation of 
soluble guanylate cyclase, adenosine diphosphate ribosylation of proteins, protein sulfhydryl 
group nitrosylation, iron regulatory factor activation and activation of nuclear factor (NF)-κB [8]. 
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NO has important effects – both physiological and pathophysiological – in wide-ranging 
processes including vascular homeostasis [9], neurotransmission [10] and the immune response 
[11]. Its most studied action is the relaxation of smooth muscle, which it effects via activation of 
soluble guanylate cyclase to form cyclic guanylate monophosphate (cGMP), eventually inducing 
dephosphorylation of myosin light-chain [6]. Unsurprisingly, NO pathway deficiency has been 
linked to pathophysiological conditions such as atherosclerosis, diabetes and hypertension [12]. 
Moreover, excessive NO is an important contributor to oxidative stress, due to its reaction with 
superoxide (O2-) to produce the damaging oxidant, peroxynitrite (ONOO-) [13], a major reactive 
nitrogen species (RNS). Briefly, NO’s major cellular actions include relaxation of vascular and 
gastrointestinal smooth muscle, inhibition of platelet aggregation, retrograde neural modulation, 
and destruction of parasites, bacteria and tumour cells [6]. 
CO, which is acquired by organisms via inhalation, metabolic by-production and 
endogenous production via the action of three heme-containing enzymes, heme oxygenase (HO)-
1, -2 and -3, succeeded NO as the second gasotransmitter [14]. While HO-2 and -3 are 
constitutive isoforms, HO-1 is an inducible stress protein associated with cytoprotection [14]. By 
virtue of CO’s bodily redistribution via carboxyhemaglobin, the locations and mechanisms of its 
biological functions are closely linked to the respiratory and cardiovascular systems. While toxic 
at high concentrations, at low concentrations it is best characterized as an anti-inflammatory and 
cytoprotective agent, and has been studied – both as a causative factor and promising therapeutic 
– in the context of pathophysiological conditions including ischemia-reperfusion (I-R) injury, 
transplant rejection, atherosclerosis, sepsis and autoimmunity [15]. Vascular SMCs and neurons 
are major CO producers, and CO induces increased cGMP via activation of soluble guanylate 
cyclase (however, its efficacy is on the order of ~30-100 times lower than NO). CO can complex 
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with any heme-containing protein, including myoglobin, iNOS, cytochrome p450 and 
cytochrome c oxidase. CO’s major cellular actions include relaxation of vascular and bronchial 
smooth muscle, anti-inflammatory and anti-apoptotic effects, and neurotransmission. It is 
metabolized via hemoglobin, with which it has an affinity on the order of ~250 times that of O2, 
producing carboxyhemoglobin, which is circulated to the lungs and excreted by diffusion [15]. 
It is important to appreciate the development of H2S research in the context of NO and 
CO because the investigations of this new gaseous transmitter have, in no small part, been 
influenced by the approaches and preconceptions of the past. Indeed, this has proven to be both 
helpful and hurtful, since while many similarities exist, many more and interesting differences do 
as well, and these have set the stage for the truly novel avenues of research that H2S offers. The 
interrelationships between NO, CO and H2S are discussed further at the end of this section. 
 
1.1 – Chemical and physical properties 
H2S is a colorless, flammable gas known for its characteristic smell of rotten eggs at 
concentrations roughly 400-fold lower than its toxic levels [3, 16]. Soluble in both polar and 
nonpolar solvents, it is unstable in physiological (pH 7.4) aqueous solutions, with approximately 
two-thirds of a given amount of H2S hydrolyzing to produce hydrosulfide ions and protons [2, 3, 
16, 17]. At sufficiently high pH, these ions can subsequently decompose to produce sulfide ions 
and protons [2, 3]. H2S is highly lipophilic, allowing it to penetrate any cell type [18]. 
 
1.2 – Toxicology 
 Sulfur, a ubiquitous, nonmetallic, greenish-yellow substance known in ancient times as 
‘brimstone’, forms many compounds including H2S [17]. This environmental and industrial 
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gaseous pollutant – considered to be one of the leading causes of sudden death in the workplace – 
is especially dangerous because it is colourless, heavier than air and undetectable by smell at 
higher concentrations [17]. Its danger is especially relevant to worker safety in Canadian 
industries such as sour gas processing – so-called due to the presence of significant 
concentrations of H2S – wherein, according to H2S toxicology expert, Dr. Sheldon Roth, H2S 
exposure safety regulations likely fall far short of being sufficiently stringent (personal 
communication). A broad-spectrum toxicant by virtue of its effects on many different tissues and 
organs, including the respiratory tract, eye, brain and olfactory system, it is those tissues with 
high O2 demand that are most susceptible to H2S due its primary mechanism of toxicity, the 
inhibition of cytochrome c oxidase [17, 19]. However, despite decades of research, a relative 
paucity of literature on the subject exists. Indeed, Roth (2004) observed that “more research is 
required on susceptible populations such as developing organisms, children, the elderly, and 
those with cardiovascular and respiratory symptoms” [17]. 
 
1.3 – Endogenous production and metabolism 
Mammalian tissues contain ‘bound sulfur’ that can be liberated via reducing agent or 
acidification as inorganic sulfide, present as H2S, HS- or S2- in aqueous phase, and as H2S in 
gaseous phase [20]. The major mammalian source of H2S is L-cysteine, which can be derived 
from the trans-sulfuration pathway, from alimentary sources or liberated from endogenous 
proteins (Figure 1) [21]. The trans-sulfuration pathway – a metabolic pathway involving the 
interconversion of cysteine and homocysteine via the intermediate cystathionine – is critical for 
creating cysteine from the essential amino acid, methionine, in eukaryotes. Here, methionine is 
first converted to homocysteine by demethylation, which is then converted to the amino acid,  
   
 21 
 
Figure 1. Enzymatic pathways of H2S production in mammalian cells. Image and text from Szabó, C. Nature 
reviews (2007). Methionine, which is derived from alimentary sources, is converted to S‐adenosylmethionine by 
methionine adenosyltransferase (MAT). S‐adenosylmethionine is subsequently hydrolysed to homocysteine by 
glycine N‐methyltransferase (GNMT). CBS catalyses the production of cystathionine by transferring serine to 
homocysteine. CSE subsequently converts cystathionine to cysteine (Cys). CSE catalyses a β‐disulphide elimination 
reaction that results in the production of pyruvate, NH4+ and thiocysteine. Thiocysteine may react with cysteine or 
other thiols to form H2S. The above reactions predominantly take place in the cytosol. In the mitochondria, cysteine 
can get converted to 3‐mercaptopyruvate by aspartate aminotransferase (AAT), which can then be converted to H2S 
by 3‐mercaptopyruvate sulphur transferase (MPST). 
 
cysteine, via the trans-sulfuration pathway. Pathway enzymes include cystathionine B-synthase 
(CBS) (EC 4.2.1.22), cystathionine y-lyase (CSE, CTH or CGL) (EC 4.4.1.1), cysteine 
aminotransferase (EC 2.6.1.3), mercaptopyruvate sulfurtransferase (EC 2.8.1.2), rhodanese (EC 
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2.8.1.1) and cysteine lyase (EC 4.2.1.10). Of these, only CBS and CSE have been shown to 
produce H2S at physiologically relevant pH and substrate concentrations [20].  
Both CBS and CSE are pyridoxal-5′-phosphate (vitamin B6)-dependent enzymes, but 
differ in their specific mechanism of H2S formation. CSE catalyzes the conversion of cystine (a 
cysteine disulfide) to thiocysteine, pyruvate and ammonia, and cystine and H2S are then derived 
from the nonenzymatic decomposition of thiocysteine [2]. By contrast, the major mechanism of 
CBS-mediated H2S production involves the condensation of homocysteine with cysteine to yield 
cystathionine, releasing H2S in the process [22]. CBS and CSE are widely distributed in tissues, 
with large amounts of CBS occurring in mammalian brain and nervous system (especially 
Purkinje cells and hippocampus) [18, 23], while CSE is the major source of H2S in the 
cardiovascular system [18, 24]. Both enzymes contribute to H2S generation in the liver and 
kidney [2, 18]. Given its prominence in the cardiovascular system and pertinence to the present 
studies, only CSE is discussed further for the purposes of this review.  
Mammalian CSE is a ~44 kDa homotetramer featuring one proteolipid protein coenzyme 
per monomer [20]. Two forms of messenger RNA (mRNA) for human CSE have been 
characterized, and likely represent splice variants, with the shorter form featuring an internal 
deletion of 132 base pairs [18, 25]. CSE expression has been demonstrated upon I-R stress [26, 
27], high glucose [28, 29], exposure to lipopolysaccharide (LPS) [30] and NO [31, 32], as well as 
in animal models of diseases including type 1 diabetes mellitus [29] and pancreatitis [33]. 
Recently, several CSE mutations have been described in patients with cystathioninuria, a rare and 
poorly understood genetic disease [34, 35]. As well, a common CSE single nucleotide 
polymorphism that converts serine to isoleucine at position 403 has been linked to elevated 
plasma homocysteine levels [34]. 
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H2S is metabolized primarily via oxidation in mitochondria and methylation in the 
cytosol, but can also be scavenged by methemoglobin or metallo- or disulfide-containing 
molecules such as oxidized glutathione (GSSG). Ultimately, it is excreted mainly by the kidney 
as free or conjugated sulfate [2, 36]. 
 
1.4 – Molecular targets 
 The H2S-synthesizing enzyme, CBS, is highly expressed in the hippocampus [37] and 
cerebellum [38], and likely represents the principal source of H2S therein, as the gas was not 
detectable in CBS knockout mice [38]. A neuromodulatory role for H2S has been suggested [37, 
39] that centres on facilitation of long-term potentiation (LTP), a synaptic model of learning and 
memory thought to involve the N-methyl- D-aspartate (NMDA) receptor as well as the release of 
corticotrophin-releasing hormone from the hypothalamus [40]. Indeed, H2S has been shown to 
induce cyclic adenosine monophosphate (cAMP) release that stimulates NMDA-receptor activity 
[39]. Furthermore, the involvement of H2S in neurodegenerative disorders has been suggested 
[41] based on evidence that H2S is decreased by 55 % in the brains of Alzheimer’s disease 
patients [42], that exogenous H2S protects neurons against amyloid-β [43], and that chronic 
exposure to H2S impairs fetal neuronal development in rats [44]. 
H2S’s novel ability to activate KATP channels [3] is arguably its most distinctive property, 
setting it apart from its gasotransmitter brethren. It has been shown to activate KATP channels in 
smooth [31, 45-47] and cardiac muscle [48-51], pancreatic β cells [28, 52, 53] and the 
hypothalamus [54]. KATP channels feature Kir6.x-type and sulfonylurea receptor subunits, and 
can be identified by their position within the cell as either sarcolemmal, mitochondrial or nuclear 
[2]. Changes in the transcription of the four identified KATP family member genes, and thus the 
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production of KATP channels, are directly linked to changes in the metabolic environment, such as 
glucose level [55] and O2 availability [56]. Briefly, the mechanism proposed for the cellular KATP 
reaction to hypoxia holds that low O2 causes decreased metabolic rate via suppression of citric 
acid cycle activity that in turn causes decreased intracellular nicotinamide adenine dinucleotide 
(NAD+)/NADH ratio and subsequent activation of phosphatidylinositol-3-kinase (PI3K) and 
extracellular signal-regulated kinases (ERK), upregulation of c-jun transcription and production 
of sur2 promoter-binding proteins that activate the KATP genes [57]. A significant implication of 
this link between metabolism and KATP production is that metabolically compromised cells are 
hypersensitive to low O2 injury, as evidenced by the diabetic susceptibility to cardiac ischemia 
[58]. Indeed, studies of both sarcolemmal and mitochondrial KATP channels indicate that they are 
critical for the cardioprotection afforded by ischemic pre-conditioning [59, 60]. Moreover, 
absence of sarcolemmal KATP channel function also impairs cardiac Ca2+ distribution [61] and 
vascular smooth muscle tone [62]. 
 Importantly for the aforementioned processes, H2S-induced cardioprotection against I-R 
injury is effected via H2S’s opening of KATP channels and regulation of Ca2+ handling [48-51, 63, 
64]. H2S-mediated KATP activation has also been implicated in H2S’s maintenance of vascular 
tone [31, 45-47] and insulin secretion [28, 52, 53, 65]; deficiency of which is thought to 
contribute to vascular pathologies including diabetes, hypertension and atherosclerosis. Here, 
other critical damaging processes exist, including elaboration of inflammation and oxidative 
stress, as well as cell over-proliferation and apoptosis. H2S has important functions in regulating 
these processes as well, and these are reviewed briefly below. 
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1.5 – Cellular actions in the cardiovascular system 
In this section, several of H2S’s most important cellular effects in the cardiovascular 
system are briefly outlined, with special focus on those relevant to the present study: redox and 
inflammatory regulation, cell proliferation and death, and mitochondrial function. Sections 3 & 4 
of this introduction expound on these cellular effects in describing H2S’s larger roles in the heart 
and vasculature, respectively. 
 Lefer (2007) observed that H2S “possesses all of the positive effects of NO without the 
capacity to form a toxic metabolite such as ONOO-” [66]. Indeed, far from being a direct source 
of free radicals, H2S has been shown to have considerable antioxidant effects. Findings from a 
variety of models support both a direct and an indirect antioxidant role for H2S. In neurons, H2S 
effects cytoprotection via induction of the important antioxidant, glutathione (GSH) [67, 68]. 
However, as GSH alone could not account for the observed antioxidant protection in these 
models, further investigation revealed that H2S has other, direct antioxidant effects in addition to 
bolstering the cells’ antioxidant defenses [68]. Interestingly, this effect of H2S on GSH occurs in 
two ways: by enhancing the production of GSH via enhancement of cystine/cysteine transporters, 
and by redistributing GSH to mitochondria. In addition, mitochondrial H2S may directly suppress 
oxidative stress [69]. Moreover, in human neuroblast cell model, exogenous H2S scavenged 
ONOO- – the RNS believed to be a major contributor to neuronal damage in Alzheimer’s and 
other neurodegenerative diseases – abrogating the redox damage and rescuing cells [70]. 
H2S also exerts antioxidant effects in animal models of I-R stress [71, 72]. Here, H2S-
mediated cardioprotection was associated with improved GSH to GSSG ratio, reduced lipid 
hydroperoxide formation and increased expression of thioredoxin-1 [71], as well as increased 
superoxide dismutase (SOD) and GSH peroxidase (GSHPx) expression [72]. Various studies 
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have demonstrated similar effects of H2S in vascular models. In carotid artery endothelial cell 
injury, H2S mitigated the subsequent vascular remodeling by balancing redox stress and 
normalizing matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) expression 
[73]. As well, in hypoxic pulmonary hypertension (HPH), endogenous H2S levels were decreased 
– suggesting an essential homeostatic role – and exogenous H2S decreased GSSG, improving 
total antioxidant capacity (T-AOC) and abrogating the HPH-induced oxidative stress [74]. 
A predominantly pro-inflammatory role for H2S has been demonstrated in animal models 
of septic/endotoxic and haemorrhagic shock [75-77], pancreatitis [33, 78-81] and carrageenan-
evoked hindpaw oedema [82], wherein enhanced H2S production was present, and inhibition of 
which attenuated inflammation [83]. Indeed, much evidence exists for a detrimental effect of 
H2S, whether as regulator or inducer of pro-inflammatory mediators such as the neuropeptide, 
substance P (SP) [84]. However, for the purposes on this review, only findings from 
cardiovascular system-specific studies will be addressed directly.  
In contrast to the principally pro-inflammatory role of H2S in models of shock, in I-R 
injury and vascular function it appears to be generally anti-inflammatory [82, 84-86], supporting 
the concept of H2S as an endogenous cardioprotectant. Elrod et al. (2007) demonstrated that H2S 
reduced neutrophilic infiltrate and myeloperoxidase activity, and prevented expression of the 
inflammatory cytokine, interleukin (IL)-1β, in the heart of I-R-injured mice [85]. As well, they 
observed H2S to completely inhibit thrombin-induced leukocyte-endothelial cell interactions, 
which was consistent with reports of H2S inhibiting aspirin-induced leukocyte rolling [86]. Zhang 
and Bhatia (2008) summarized the mechanisms by which H2S regulates inflammatory mediators 
and modulates leukocyte rolling and adherence as follows: (a) stimulation of mitogen-activated 
protein kinase (MAPK)-NF-κB pathway and/or KATP channels; (b) promotion and release of 
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neuropeptides such as SP; (c) regulation of leukocyte survival and proliferation [87]. Further 
studies are required in order to clarify H2S’s inflammatory effects, particularly in cardiac tissues 
given the striking, but otherwise largely unsupported findings [85]. 
Vascular relaxation is absolutely dependent on proper coordination between endothelial 
and smooth muscle cells (SMCs), and arterial resistance increases with the proliferation of these 
cells [88]. Consistent with its role in regulating vascular tone and involvement in vascular 
pathophysiology, H2S has been shown to have important effects on SMC relaxation [4, 89-93], 
proliferation [93-96] and death [93-95, 97, 98]. Indeed, taken together with its aforementioned 
redox and inflammatory effects, H2S has rapidly been established as a critical regulator of 
vascular homeostasis [21, 99], a subject discussed in detail in Section 4 of this introduction 
Finally, the mitochondrion has recently become a key area of H2S research. Mitochondrial 
KATP channels have been implicated as molecular targets of H2S, and their activation has been 
variously linked to anti-apoptotic [100] and pro-apoptotic [101] effects alike. Interestingly, H2S 
was cardioprotective against myocardial I-R injury via stabilization of mitochondrial structure 
and function [85]. Consistent with H2S’s potent and reversible inhibition of cytochrome c 
oxidase, H2S dose-dependently reduced oxidative phosphorylation in cardiac mitochondria, and 
that this prevented I-R damage subsequent to myocardial infarction (MI) [85]. Indeed, as per the 
recent demonstration that H2S can induce a suspended animation-like state in mice that protects 
against hypoxic damage [102, 103], H2S-mediated suppression of metabolism is likely protective 
for two related reasons: (a) reduced ROS by-production (and therefore reduced ROS-induced 
damage), and (b) reduced cellular O2 demand (and thus entrance into an adaptive, pro-survival 
mode). Further to the importance of the mitochondrion to H2S’s cellular functions, Olson et al. 
(2009) demonstrated that the consumption of exogenous H2S by cardiac mitochondria was O2-
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dependent, which is consistent with their newly proposed concept of O2-sensing via H2S 
metabolism [104]. These concepts are discussed in more detail in Section 5 of this introduction. 
 
1.6 – Gasotransmitter interactions 
Sufficient evidence for important gasotransmitter interaction across mammalian and non-
mammalian systems led Li and Moore to recently remark that “it may now be necessary to view 
these gases not as separate entities but as a triumvirate of molecules working together to regulate 
cell function in health and disease” [18]. While important relationships are suspected among all 
of the recognized gasotransmitters, such interaction is most clearly evident between NO- and CO-
generating systems, which share similar modes of production and effects, such as relaxation of 
blood vessels via augmentation of cGMP in vascular SMCs [32]. Interestingly, some of NO’s 
vasorelaxant effect is imparted via its direct and indirect (via triggering of heme release) 
induction of HO-1 expression, and the resultant increase in CO [105]. Moreover, CO directly 
inhibits iNOS via binding to its heme moiety, thereby acting as a cytoprotective factor in limiting 
excessive NO synthesis, such as often exists during oxidative stress [32, 105]. Thus, this synergy 
may also serve an adaptive function, such as in atherosclerotic vessels, wherein stress-responsive 
HO-1 activity could compensate for deficient NO production and function, thereby maintaining 
vascular tone [106].  
Similarly, evidence of synergy between NO and H2S exists. For example, NO blockade 
was found to dampen H2S-induced relaxation of aortic rings; an effect replicated upon removal of 
endothelium [31]. However, despite the indication that H2S induces NO that contributes to its net 
vasorelaxant effect, researchers have subsequently presented contradictory findings for such an 
effect, likely stemming from differences in sample preparation and experimental approach. 
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Indeed, reports of both left- and right-ward shifts in dose response smooth muscle relaxation 
curves exist, as well as mechanisms that do and do not centre on cGMP [31, 107-109]. 
Interestingly, NO has been found to increase endogenous H2S production in a dose-dependent 
manner, suggesting a direct stimulatory effect of NO on CSE that may originate downstream of 
cGMP and/or via NF-κB [31, 32]. The recent important finding by Yang et al. (2008) that H2S 
shares a much more considerable amount of the vasorelaxation workload with NO than 
previously appreciated suggests that it be considered as an equal partner, opening new, parallel 
avenues for the treatment of hypertension [99]. 
 As Li and Moore recently observed, the answer to the question of how a single molecule, 
H2S, can exert such wide-ranging and often contradictory cellular effects may lie in its interaction 
with its fellow gasotransmitters. That is, much may depend, and in a very localized fashion, on 
the larger balance of NO, CO and H2S synthesis, activity and/or stability [18]. The onus, then, is 
on gasotransmitter biologists to consider the potential contributions of this so-called “triumvirate” 
when designing experiments that seek to deconstruct these mysterious gaseous mediators. 
 
2 - The redox and inflammatory bases of cardiovascular disease 
Among the noncommunicable diseases, cardiovascular disease is the leading cause of 
death globally, accounting for 30 % of all deaths – or about 17.5 million people – in 2005 [110]. 
Although typically considered a disease of developed countries, its incidence is increasing in the 
developing world [110]. Cardiovascular disease usually stems from vascular dysfunction – for 
example, as a result of atherosclerosis, thrombosis or high blood pressure – which then 
compromises organ function. Most notably, the heart and brain can be affected, as occurs in 
myocardial infarction and stroke, respectively. For heart disease in particular, a wide range of 
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underlying pathologies can lead to defective functioning of the heart muscle. A wide variety of 
stimuli and mechanisms, many of which operate simultaneously, contribute to the cardiac 
remodeling that can ultimately lead to heart failure. Pronounced oxidative stress, immune 
activation and inflammation are increasingly recognized as key features within many of these 
processes. Indeed, elevated oxidative stress [111-115] and inflammation [116-125] that correlate  
 
Figure 2. Oxidative, inflammatory and neurohumoral mediators initiated by myocardial stress, inform the 
development and progression of heart failure. Reactive oxygen species and inflammatory cytokines can contribute 
to the initial myocardial injury, act as or stimulate myriad secondary messengers such as neurohormones, and induce 
or exacerbate ventricular remodeling processes including hypertrophy, fibrosis, apoptosis, autophagy and necrosis. 
Thus, oxidative stress and inflammation are integral aspects of the pathogenesis of cardiac dysfunction and heart 
failure, with both their abundance and potency amplifying with the deterioration of the failing heart [13]. 
 
with the severity of disease have been reported in a variety of pathophysiological conditions 
including hypertension, atherosclerosis, coronary artery disease, cardiomyopathy and heart 
failure. Most of the components of neurohumoral and inflammatory activation such as 
catecholamines, angiotensin II, aldosterone and pro-inflammatory cytokines observed in heart 
failure induce oxidative stress through diverse mechanisms (Figure 2) [126-128]. In this regard, 
there has been special interest of late in the pathological relevance of the interrelation and 
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interaction of oxidative stress and inflammatory cytokines in cardiovascular disease. 
 
2.1 – Oxidative stress 
Oxidative stress refers to the total burden of potentially harmful ROS that form during 
cellular metabolism. Potential endogenous sources of free radicals include the mitochondrial 
electron transport chain, NADH/NADPH oxidase, the xanthine-xanthine oxidase system and 
many other redox reactions. Examples of ROS include O2- anion, hydrogen peroxide (H2O2), 
hydroxyl radical and hypochlorous acid. RNS include free radicals such as NO as well as non-
radicals such as ONOO-, which is generated via the ready reaction of NO and O2-. ROS and RNS 
trigger a cascade of harmful events including DNA damage, protein nitration, lipid peroxidation 
and activation of MMPs, contributing to cardiac remodeling via alteration in Ca2+ flux [129, 130]. 
As a defense mechanism, cells have evolved various enzymatic (i.e. SOD, catalase and GSHPx) 
and non-enzymatic antioxidants (i.e. GSH and antioxidant vitamins) that detoxify free radicals. 
When an abundance of ROS, from endogenous or exogenous influences, exceeds the capacity of 
the antioxidant defenses to detoxify them, oxidative stress results [114, 129].  However, despite 
these detrimental effects, it is essential to note that ROS generated under physiological conditions 
play important beneficial roles, including their acting as signaling molecules in a variety of cell 
signaling pathways, often as second messengers. Indeed, ROS act to modulate the activity of 
specific transcription factors including NF-κB and activator protein (AP)-1, and are also integral 
to defense mechanisms such as oxidative burst in phagocytosis, neutrophil function and shear 
stress-induced vasorelaxation [114, 129, 131].  
Oxidative stress is involved in a variety of pathophysiological conditions, such as I-R 
injury, hypertrophy and heart failure, hypertension, catecholamine-induced cardiomyopathy, 
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diabetic cardiomyopathy and adriamycin-induced cardiomyopathy [111, 115, 131-133]. For 
example, in patients with dilated cardiomyopathy and congestive heart failure, plasma 
malondialdehyde (MDA) – a marker of oxidative stress – is increased, correlating with the 
severity of symptoms and inversely correlating with ejection fraction and exercise capacity [112, 
128]. Similarly, an increase in oxidative stress and a deficit in antioxidant level have been 
reported in various animal studies related to cardiovascular complications [111, 114, 115, 132, 
134].  
Substantial evidence has implicated ROS signaling in cardiac hypertrophy. ROS 
stimulates myocardial growth and matrix remodeling in cardiac hypertrophy through a variety of 
signaling kinases and transcription factors such as tyrosine kinase, Src, guanosine triphosphate 
(GTP) binding proteins, Ras, protein kinase C (PKC) and ERK and jun n-terminal kinase (JNK) 
signaling [114, 130, 133, 135, 136], leading to altered signal transduction, calcium regulation and 
apoptosis [130, 132, 137, 138]. This modifies the collagen and overall matrix arrangement [139] 
resulting in further apoptosis, fibrosis or necrosis (referred to as ventricular remodeling), leading 
to cardiac dysfunction. ROS also play an important role in cardiac remodeling by angiotensin II 
and activation of AP-1 [140]. Moreover, it is increasingly recognized that ROS are both a 
contributor to and product of many cardiovascular disease processes, such that a positive 
feedback relationship can exist. It is for this reason that ROS level is generally observed to scale 
with the severity of disease [13]. 
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2.2 – Inflammation 
Like oxidative stress, inflammation represents an integral aspect of homeostatic regulation 
that can exert both beneficial effects and contribute to disease pathogenesis. Inflammation is a 
tightly regulated, complex tissue response to harmful stimuli that attempts to attenuate stressors 
and is also involved in the healing process [118, 119, 125, 141]. The inflammatory response is 
mediated by a variety of signaling molecules, including prostaglandins and C-reactive protein, 
soluble cluster of differentiation (CD)-40 ligand, adiponectin and inflammatory cytokines, such 
as tumour necrosis factor (TNF)-α. Many of these are increasingly used as biomarkers for the 
systemic inflammation associated with cardiac remodeling and heart failure [118, 141, 142]. 
Cytokine signaling is essential for the function of the innate and adaptive immune system, 
playing numerous roles in the host’s inflammatory response including chemoattraction of 
neutrophils, monocytes and dendritic cells by chemokines, and triggering of fever [118, 119]. In 
short, inflammatory cytokines are ubiquitous, critical mediators of the protective inflammatory 
response to a wide variety of harmful or potentially harmful stimuli throughout the body. 
However, in pathophysiological conditions the dysregulation of various processes can lead to 
chronic inflammation, where the unchecked activity of inflammatory mediators and processes can 
be massively damaging [119, 141, 143]. 
Pro-inflammatory cytokines have been shown to contribute to cardiac dysfunction under 
various pathophysiological conditions associated with heart failure, including I-R injury, MI, 
atherosclerosis, hypertrophy, and acute viral myocarditis [116, 121, 122, 124, 125, 128, 144-149]. 
Inflammatory cytokines may modulate cardiovascular function by various mechanisms including 
altered adrenergic signaling, increases in NO or alteration of Ca2+ homeostasis and redox balance 
[134, 150, 151]. Several studies have shown that the inflammatory response resulting from MI 
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serves to further exacerbate myocardial injury, leading to deleterious remodeling of the heart and 
of the extracellular matrix. This can include MMP activation and excess collagen formation, 
increased apoptosis and hypertrophy, and, importantly, self-amplification of the inflammatory 
signal transduction pathways leading to depressed contractility [119, 143, 152-156].  
 
2.3 – The ‘vicious cycle’ of redox-cytokine interaction 
Besides its central role in challenging and aggravating myocardial injury directly, the 
oxidative stress pathway is demonstrably connected with key aspects of the inflammatory 
response. Recent findings suggest that oxidants promote inflammatory processes via the 
activation of downstream, redox-sensitive factors such as NF-κB, AP-1, and p38 MAPK, leading 
to the induction of various inflammatory cytokines [130, 137, 138, 143, 157-159]. In this way, 
oxidative stress contributes to the development of cardiovascular disease both directly and 
indirectly. Conversely, pro-inflammatory cytokines and chemokines have been implicated in the 
cascade of events leading to increased oxidative stress, which, in turn, contributes to disease 
progression via intensification of the inflammatory response [126, 134, 135, 151, 160]. Moreover, 
components of neurohormonal activation, such as catecholamines, angiotensin II, aldosterone, 
and endothelin (ET)-1 are potential contributors to the pro-inflammatory phenotype of heart 
failure and have been shown to enhance oxidative stress both directly and indirectly [127, 136, 
161, 162].  
Thus, current literature indicates that increased pro-inflammatory cytokine expression and 
ROS production are linked in a ‘vicious’, perpetuating cycle that may be of major significance in 
the development and progression of cardiovascular diseases leading to heart failure (Figure 3). In 
the following sections, the pro-inflammatory cytokine, TNF-α, and the anti-inflammatory 
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cytokine, IL-10, are discussed in detail, as these mediators in particular have received the greatest 
attention in the literature with regard to their effects on oxidative stress. 
 
Figure 3. The ‘vicious cycle’ of inflammatory cytokine expression and oxidative stress and the stress response 
spectrum leading to heart failure. Linkages between oxidative stress and inflammatory cytokine/chemokine 
expression have been documented in the pathophysiology of heart failure. Both pathways exist in delicate balance 
between their respective pro-oxidant/pro-inflammatory and antioxidant/anti-inflammatory elements, and each has 
been shown to correlate with the severity of disease. These pathways also interact at a more global level, with TNF-α 
and other pro-inflammatory mediators contributing to the production of ROS, which in turn stimulates the expression 
of more such mediators, leading to a perpetuating, ‘vicious cycle’ of increasing systemic stress. Both pro-
inflammatory cytokines such as TNF-α, and ROS activate transcription factors such as NF-κB and AP-1, which 
regulate the expression of a broad variety of stress response pathways. The extent of the response depends on the 
intensity and duration of the stimuli, and thus can range from acute to chronic in nature, producing phenotypic 
changes ranging from adaptive (hypertrophy, survival, differentiation, antioxidant response, anti-inflammatory 
response) to maladaptive (fibrosis, apoptosis, autophagy, necrosis, pro-oxidant response, pro-inflammatory 
response). This continuum is evident in the cardiac remodeling changes from normal to compensatory hypertrophy to 
heart failure. Importantly, inflammatory cytokines and ROS both stimulate the stress response and are regenerated by 
it, creating yet another common, positive feedback cycle that scales with disease progression [13]. 
 
2.4 – Tumour necrosis factor-α and oxidative stress 
Although cross-promotion of inflammatory cytokines and oxidative stress may be 
manifested in many ways, the vast majority of research has specifically focused on the link 
   
 36 
between oxidative stress and TNF-α. The most prominent of inflammatory cytokines, TNF-α, is 
expressed in numerous cell types, including macrophages, monocytes, T and B cells, mast cells, 
and cardiomyocytes. TNF-α exerts its effects via specific receptors (TNFR1 and TNFR2), and 
both the soluble and membrane bound TNF-α forms are capable of activating these receptors 
[163]. TNF-α acts as a master mediator of cytokine and other downstream pathways, and, 
consistent with its normal physiological role in the innate and adaptive immunity, it is a key 
factor in the host response to injury. However, this function can also be detrimental within a 
disease state such as that within the infarcted myocardium, where exaggerated TNF-α signaling 
via activation of other pro-inflammatory mediators such as IL-1β, IL-18 and the IL-6 family 
cytokines, can exacerbate an already highly stressed environment [117, 138, 141, 164].  
Numerous studies have demonstrated a link between TNF-α and ROS. For example, 
increases in oxidative stress, cellular injury and apoptosis have been shown upon exposure to 
TNF-α [126, 135, 137]. TNF-α has been reported to contribute to progressive cardiac 
dysfunction in pacing-induced heart failure that is mediated by an increase in oxidative stress and 
apoptosis [165]. This is accompanied by impaired mitochondrial function, and in vivo TNF-α 
inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress and apoptosis in this 
model [165]. TNF-α enhanced the formation of NO, O2- and ONOO- via the stimulation of iNOS, 
xanthine oxidase and NADPH oxidase activities, contributing to depressed cardiac function in 
isolated perfused hearts of both rats and mice [150, 151, 166]. Increased formation of ONOO- by 
cytokines other than TNF-α, such as IL-1ß and IFN-γ, has also been reported in cardiomyocytes 
[167].  
The potential for antioxidant-based regulation of TNF-α levels has been suggested in 
rodent models of MI and hypertension [152, 168]. In these studies, treatment with the GSH 
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precursor NAC was found to normalize serum and/or cardiac TNF-α, TNF-R1 and GSH levels, 
attenuate MMP expression and collagen deposition, and improve cardiac function. In other rodent 
studies of I-R injury, the antioxidant, probucol, was found to decrease levels of cardiac MDA and 
expression of IL-1β and IL-6, and to augment levels of GSHPx and catalase, contributing to 
cardioprotection and increased survival [169]. Importantly, therein was evidence of common 
TNF-α and redox-sensitive signaling pathway activation, as TNF-α was reported to activate 
multiple targets, including p38, JNK and ERK1/2 MAPK, as well as stimulating the 
phosphorylation of c-jun and activating transcription factor-2 [135, 153, 157, 164, 170, 171]. 
Activation of these factors can result in a diverse number of intracellular events including 
alterations in gene expression and apoptosis. Furthermore, both TNF-α and ROS can induce 
activation of transcription factors such as NF-κB and AP-1 [138]. In addition to TNF-α, there 
have only been a few studies on the interaction between chemokines and ROS. One such study 
demonstrated that MCP-1 enhanced the generation of O2- in monocytes from unstable angina 
patients and GSH modestly suppressed the production of IL-8 and MCP-1 in these cells, 
demonstrating an interaction between MCP-1 and ROS and its possible pathogenic role in plaque 
rupture [160]. Lipase activation and liberation of arachidonic acid and prostaglandins are also 
responsible for the production of ROS and oxidative stress by TNF-α [172]. 
 
2.5 – Interleukin-10 and oxidative stress  
In contrast to TNF-α, IL-10 has been reported to have an antioxidant role, and has been 
shown to inhibit the formation of ROS as well as the production of NO [173, 174]. The initial 
suggestion that IL-10 might act as an antioxidant was reported by Bogdan et al. (1991), wherein 
recombinant IL-10 was found to suppress both TNF-α expression and ROS production in mouse 
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peritoneal macrophages [175]. Consistent with these findings, IL-10 was also suggested to 
modulate TNF-α mediated, oxidative stress-induced lung injury, a condition found to be 
augmented by the application of IL-10 antibody [176, 177]. In a murine renal model of I/R injury, 
IL-10 treatment reduced lipid peroxidation, while increasing the redox ratio and antioxidant 
enzyme activity [178]. IL-10 was previously shown to activate the ERK1/2 MAPK pathway, and 
evidence of p38 and ERK1/2 MAPK-mediated regulation of TNF-α/IL-10 interaction has 
recently been shown [135]. Here, it was also found that TNF-α significantly increased ROS levels 
and cardiomyocyte apoptosis, whereas these changes were prevented by the inclusion of IL-10 
[135].   
 
2.6 – Implications for interleukin-10/tumour necrosis factor-α ratio 
Recently, it has been shown that in a rat model of MI, TNF-α exhibits a biphasic 
response, featuring decreased levels in the early stage and a return to higher levels during the 
chronic stages of heart failure. This response correlated with increased and decreased IL-10 levels 
in the early and chronic stages, respectively. Thus, increased IL-10:TNF-α in the early stages and 
decreased IL-10 to TNF-α ratio in the severe failure stages was observed [179]. A similar 
increase in TNF-α:IL-10 was also reported in patients with advanced congestive heart failure 
[180], and an imbalance between IL-10 and TNF-α has also been suggested to play a role in 
atherosclerotic lesions [181]. It has been further demonstrated that treatment with losartan, an 
angiotensin II type 1 receptor blocker, improved the ratio of membrane-bound as well as soluble 
fractions of IL-10:TNF-α protein in a rat model of MI [179]. Post-MI losartan-treated rats 
showed improved antioxidant status and hemodynamic function [111, 179]. Taken together, these 
studies strongly suggest that the two cytokines may interact in influencing oxidative stress and 
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that an appropriate balance between them may be of crucial importance for mitigating conditions 
leading to heart failure [179, 182, 183]. These findings are further supported by the recent finding 
of common regulatory mechanisms – p38 and ERK 1/2 MAP kinases as well as NF-κB pathway 
– that govern the interplay of TNF-α and IL-10 in regulating oxidative stress and cardiomyocyte 
apoptosis [135, 170]. Moreover, it has recently been reported that IL-10 prevents TNF-α-induced 
NF-κB activation and pro-apoptotic changes in cardiomyocytes by inhibiting IKK 
phosphorylation through the activation of ERK 1/2 MAPK [170].  
 
3 – Hydrogen sulfide is a cardioprotective agent 
Deficiencies resulting in reduced blood flow (and thus O2 supply) or increased cardiac 
wall stress (and thus greater metabolic demand) produce conditions of low O2, or hypoxia, in the 
heart. Indeed, tissue ischemia is the major pathophysiological end point of many disease 
processes, including cardiac arrest, shock, MI and stroke [184]. Cardiac ischemia results from 
progressive congestive cardiovascular processes of coronary artery disease, a leading cause of 
death in Canada (Heart and Stroke Foundation of Canada. The Growing Burden of Heart Disease 
and Stroke in Canada. Ottawa: Heart and Stroke Foundation of Canada, 2003). However, 
although an obligatory component, hypoxia represents only one aspect of the stress visited upon 
the ischemic heart. Indeed, while insufficient perfusion of cardiac tissues can be devastating, the 
return of blood, or reperfusion, is typically far more damaging [185]. These processes – 
collectively known as I-R injury – represent a major source of cardiac damage in many 
cardiovascular diseases, imparting massive oxidative stress to cardiovascular tissues by 
generating high levels of ROS by virtue of the profound influx of O2 [185]. As described in 
Section 2 of this introduction, redox imbalance begets elaboration of inflammatory mediators, 
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which begets more ROS production, in a ‘vicious cycle’ of redox-cytokine interaction that 
underscores much of the pathophysiology of cardiovascular disease.  
Two major strategies for abrogating the harmful effects of I-R are pre-conditioning and 
post-conditioning. While pre-conditioning has long been studied and is considered one of few 
powerful protective mechanisms against cardiac and cerebral ischemia, post-conditioning is a 
relatively novel concept [186]. Put simply, these are protective responses by the heart and other 
organs to sublethal levels of hypoxia or ischemia, resulting in the induction of adaptive 
physiological processes [185].  Both pre- and post-conditioning consist of one or more short 
ischemic/hypoxic events, differing mainly in their temporal application (i.e. either prior to or 
during I-R). Whereas pre-conditioning can render a naïve heart more resilient to subsequent I-R, 
post-conditioning can limit the reperfusion damage stemming from it [237]. 
Both pre- and post-conditioning elicit signaling cascades relating to reduced cell death 
and mitochondrial preservation, including those mediated by adenosine, eNOS and NO, the 
opening of KATP channels, and ERK1/2 and PI3K/Akt activation [187]. Importantly, H2S’s known 
biological activities include these targets/mediators, suggesting the potential for a role therein. 
However, given the contradictory evidence, the question remains open. Indeed, while endogenous 
H2S has been implicated in ischemic [188, 189], metabolic inhibition [64] and endotoxin [51]-
mediated pre-conditioning, other studies have demonstrated that inhibition of endogenous 
H2S/CSE pathway did not affect ischemic pre-conditioning [51, 190]. In these studies, 
endogenous H2S-mediated contributions to cardioprotection against I-R injury were associated 
with PKC and sarcolemmal KATP channel activation [51, 188] and provocation of NO release 
[64], but not protein kinase phosphorylation [190].  
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There is more coherence regarding the effect of sulfide pre-conditioning (typically via the 
H2S donor, NaHS), which has been shown to produce effective cardioprotection from I-R injury 
in a manner similar to ischemic pre-conditioning [50, 189-194]. With the exception of one study 
[190], this cardioprotection was found to be mediated by PI3K/Akt and KATP/PKC/ERK1/2 
pathway activation and NO, and was found to induce cyclooxygenase-2 expression/activation 
[50, 189, 191, 193, 194]. Furthermore, in a recent study of sulfide pre-treatment of I-R injury in 
small intestine, H2S prevented leukocyte rolling and adhesion via an eNOS- and p38/MAPK-
dependent mechanism [195].  
Endogenous H2S was also implicated in ischemic post-conditioning [196], and, as with 
sulfide pre-conditioning, sulfide post-conditioning was found to provide cardioprotective effects 
in a similar manner to ischemic post-conditioning [196, 197]. In these ex vivo rat models of I-R 
injury, H2S given at the onset of reperfusion (sulfide post-conditioning) resulted in concentration-
dependent decreases in infarct size and creatine kinase release. This effect was mediated by Akt, 
PKC and eNOS, and blockade of either CSE or KATP channels attenuated the observed 
cardioprotection [196, 197]. 
Although research on the processes underlying myocardial injury abounds, endogenous 
responses that protect cellular and subcellular functions – and especially mitochondria – during 
ischemic heart disease remain poorly understood and are not targeted in current therapeutic 
strategies [185]. As the centre of aerobic respiration, the mitochondrion is, ironically, both the 
primary source of [198] and the most susceptible cellular component affected by I-R-induced 
ROS [199, 200], as evidenced by the profound increase in oxidative stress [201] and decrease in 
aerobic energy production [202] upon reperfusion. Thus, as a key target of protective responses to 
hypoxia and the central integrator of O2 and fuel substrate metabolism, as well as a central locus 
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for the regulation of cell death [85, 203, 204], the mitochondrion is the most important focal point 
of I-R injury. Recently, Elrod et al. (2007) noted that H2S preserved cardiac function and limited 
infarct size via stabilization of mitochondrial structure and function. They found that H2S dose-
dependently reduced oxidative phosphorylation, preventing I-R damage subsequent to MI [85]. 
Moreover, in anesthetized and mechanically-ventilated mice, inhaled H2S improved 
mitochondrial respiration by enhancing mitochondrial integrity, suggesting its potential benefit 
during therapeutic hypothermia [205]. 
While there is a certain level of ambiguity in terms of H2S’s role in pre- and post-
conditioning, its role in the myocardium itself is clearer, despite only a few years of data. In 
multiple studies, cardiac injury was associated with reduced H2S/CSE pathway expression [206-
209]. Several studies have demonstrated that the cardioprotective effects of the garlic derivative, 
S-allylcysteine (SAC), are mediated by H2S [192, 210]. Left ventricular CSE expression and 
plasma H2S was increased by SAC administration in acute MI rats, and infarct size was increased 
upon inhibition of H2S/CSE pathway [210]. In addition, the vasoactivity of garlic was similarly 
shown to operate via an H2S-mediated mechanism [211]. In two mouse models of heart failure, 
exogenous H2S preserved cardiac function and reduced fibrosis [206], as well as reducing 
cardiomyocyte apoptosis [212]. In another study, the H2S-mediated reduction of cardiomyocyte 
apoptosis was shown to operate via induction of glycogen synthase kinase-3β and subsequent 
inhibition of mPTP opening [213]. As well, in two models of homocysteine-induced cardiac 
stress, exogenous H2S attenuated endoplasmic reticulum stress and rescued cells [207], as well as 
improving redox balance [208]. Finally, in a model of adriamycin-induced cardiomyopathy – 
wherein endogenous H2S/CSE pathway was compromised – exogenous H2S markedly improved 
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cardiac function, ameliorated myocardial morphology, decreased thiobarbituric acid reactive 
substances and increased SOD and GSHPx [209]. 
Thus, having been shown to play key regulatory and/or protective roles in terms of 
preserving mitochondrial structure and function, regulating redox and inflammatory status, and 
modulating ion channels and metabolism, H2S is certainly one answer to the question of a multi-
faceted endogenous cellular regulator. Given the variability within the existing I-R models, such 
as the duration and extent of ischemic episodes and the method of heart failure induction, it will 
be important to carefully consider the timing of CSE inhibitor and H2S donor application, as well 
as to monitor for temporal changes in channel activation and mRNA/protein expression alongside 
functional readouts. In particular, more attention should be paid to the redox and inflammatory 
aspects of H2S’s cardioprotection, since little, but promising data is currently available. 
 
4 – Hydrogen sulfide in vascular pathophysiology 
The roots of H2S’s arrival as an intriguing gasotransmitter lie in the discovery of its KATP-
mediated vasorelaxant effect. Indeed, like its NO forebear, it is now recognized as both a critical 
regulator of vascular tone and an important factor in the pathophysiology of various vascular 
conditions, including hypertension, atherosclerosis and diabetes. Indeed, a now extensive 
literature supports the need for H2S-based therapeutics to combat the modern scourge of vascular 
disease, and these hold great promise to someday rival the incredible impact that the discovery of 
NO has had over the past two decades. 
In 2008, Yang et al. presented important new findings demonstrating that genetic deletion 
of the H2S-synthesizing enzyme, CSE, markedly reduced serum and aorta and heart tissue H2S 
levels [99]. Importantly, knockout mice displayed pronounced hypertension and decreased 
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endothelium-dependent vasorelaxation, providing direct, compelling evidence for H2S’s role as 
physiologic vasodilator and regulator of blood pressure. Furthermore, given that H2S-deficiency 
(CSE knockout) caused elevated blood pressure and increased peripheral resistance to a similar 
extent as that observed in NO deficiency (eNOS knockout), the drastic impact of H2S on 
regulation of the vasculature was realized, thereby opening novel avenues for treating 
hypertension [99]. This section summarizes much of the data that preceded these findings, and 
emphasizes the myriad effects that have already been attributed to H2S in the pathophysiology of 
vascular diseases including HPH, atherosclerosis and diabetes. 
Pulmonary hypertension is an important pathological process underlying many 
cardiovascular and pulmonary diseases that can ultimately lead to heart failure, but its 
mechanisms remain poorly understood [214]. Multiple groups have researched H2S’s role in 
pulmonary hypertension induced by hypoxia, high blood flow, and endotoxin, with the common 
pathological result of inducing pulmonary arterial remodeling and vasoconstriction. In rat models 
of HPH, significantly decreased CSE expression and activity in pulmonary artery and lung tissue 
of hypoxic animals was observed, indicating that endogenous H2S was involved in the 
pathogenesis of the condition. By contrast, researchers noted that exogenous H2S administration 
produced marked preservation/recovery of functional parameters, including decreased mean 
pulmonary arterial pressure [161, 215-224]. It was found that H2S effected this protection through 
various mechanisms, including the abrogation of oxidative stress through decreased GSSG and 
enhanced T-AOC in lung tissues [161, 220], the inhibition of collagen types I and III expression, 
elastin, and TGF-β [217, 221], the inhibition of vascular SMC proliferation [217], the promotion 
of vascular SMC apoptosis via inhibition of Bcl-2 protein expression and activation of Fas and 
caspase-3 protein expression [215], and the upregulation of HO-1 expression and increased CO 
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production [219]. It was also found that a negative, but apparently essential, feedback relationship 
existed between H2S and NO in HPH rats, such that inhibition of either CSE or NOS resulted in 
the worsening of the condition [222].   
Other researchers used a rat model of LPS-induced pulmonary arterial hypertension, again 
implicating decreased H2S/CSE in the impaired relaxation leading to maladaptive vessel 
constriction [218]. Similarly, in rat models of high blood flow-induced pulmonary hypertension, 
in which aorta-inferior vena cava-shunted animals developed pronounced pulmonary high blood 
flow and vascular structural remodeling, H2S/CSE levels were also markedly downregulated 
[214, 225]. The NOS substrate, L-arginine, had previously been shown to attenuate pulmonary 
hypertension and vascular remodeling [220, 226], and was found to significantly upregulate 
H2S/CSE pathway, indicating a H2S-mediated mechanism of action [214]. Moreover, H2S was 
subsequently shown to be protective against pulmonary hypertension and vascular remodeling, 
and correlated with suppressed NO/NOS and CO/HO-1 pathways, and proliferative cell nuclear 
antigen and ERK downregulation [227].  
 Taken together, these data indicate an important role for H2S in hypoxic, high blood flow, 
and endotoxin-induced pulmonary hypertension and vascular remodeling, variously serving as an 
antioxidant, anti-proliferative and/or pro-apoptotic agent, as well as a potential regulator of NO 
and CO. The common finding of inter-regulation among the H2S/CSE, NO/NOS and CO/HO-1 
pathways in pulmonary hypertension is especially interesting given that all three gasotransmitters 
are potent vasodilators and modulate vascular remodeling. Indeed, the observed dysfunction of 
these pathways in the pathogenesis of this condition suggests the potential for intriguing 
combinational approaches to therapy. 
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Atherosclerosis is a complex, chronic pathological condition comprised of vascular 
inflammation, endothelial damage, SMC migration, foam cell accumulation and lipid and 
cholesterol deposition that begets plaque formation in blood vessels [228]. Evidence for an 
important role for H2S in combating atherosclerosis includes the observations that it is anti-
atherogenic [229-232], and inhibits SMC proliferation [93, 95] and homocysteine-induced 
vascular damage [88, 233]. Central to the present data is the question of basal H2S level and or 
interaction of endogenous with exogenous H2S, given that the latter had no effect in inducing 
apoptosis of SMCs without inhibition of the former [93, 95]. More recently, it was demonstrated 
that exogenous H2S reduced atherosclerotic plaque while inhibition of endogenous H2S 
exacerbated it, and that H2S’s anti-atherosclerotic effect was linked to reduced expression of the 
key inflammatory mediator, ICAM-1, in TNF-α-induced endothelial cells [228, 230]. Wang 
(2009) suggests that, because SMC-endothelial cell interaction is critical to atherosclerotic 
processes, the question of where H2S is being produced and how its signaling affects these cells is 
an important one that, by virtue of recent advances in our understanding of CSE distribution in 
vascular tissues, may soon be answered [228].  
Diabetes is properly understood to be included in the realm of cardiovascular disease, as 
its essential nature – compromised glucose metabolism – is so critically disruptive as to all but 
inevitably lead to cardiovascular complication. Perhaps unsurprisingly, given its clear roles in the 
pathophysiology of vascular disease and effects that centre on the mitochondrial regulation and 
metabolism, recent research has established the involvement of H2S in processes underlying the 
pathogenesis of diabetes mellitus. Researchers observed abnormally high H2S levels in the liver 
[29] and pancreas of diabetic rats [28, 29] and found H2S to induce apoptosis therein via p38 
MAPK-mediated ER stress [65]. H2S levels were similarly decreased in another animal model of 
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diabetes, wherein vascular reactivity was also found to be impaired [234, 235]. Interestingly, as 
has been demonstrated in other models [93, 95], the effect of exogenous H2S was most 
pronounced in the absence of endogenous H2S [234], reinforcing the concept that basal H2S level 
is essential in determining response. Consistent with these findings, recent evidence suggests that 
H2S could be a novel insulin resistance regulator, as H2S/CSE pathway was inversely correlated 
with glucose uptake in adipose tissue [236]. Interestingly, PI3K but not KATP channel pathway 
was involved in the observed inhibitory effect of H2S on glucose uptake [236]. A significant 
recent publication suggests the generalizability of these concepts, as H2S levels in both fasting 
blood of type 2 diabetes patients and diabetic rats was significantly lower than healthy controls 
[237]. Moreover, exogenous H2S was found to prevent secretion of the inflammatory mediators, 
IL-8 and MCP-1, in high-glucose-treated human monocytes, suggesting that low H2S levels may 
contribute to the vascular inflammation present in diabetes [237]. Further research is required, 
particularly in terms of the signaling mechanisms involved, but these data collectively indicate 
yet another cardiovascular disease wherein H2S is a critical player.  
 
5 – Is hydrogen sulfide a novel oxygen sensor? 
H2S has been implicated in the adaptive physiological responses to I-R injury as a 
powerful endogenous cardioprotectant, and has critical roles in maintaining vascular homeostasis, 
as evidenced by its role in vascular pathophysiology. In particular, the essential contribution 
H2S/CSE pathway to ischemic pre- and post-conditioning and the parallel effects of sulfide 
conditioning strongly suggest that H2S has a hypoxia-responsive capacity in the cardiovascular 
system. Importantly, new evidence has led to the arrival of the novel concept of H2S metabolism 
as an O2-sensing mechanism, further bolstering the concept of H2S as a central cardiovascular 
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regulatory molecule. A discussion of this newly discovered role for H2S begins with a brief 
description of our current knowledge of the mammalian O2-sensing landscape. 
Molecular O2 serves as the primary electron acceptor in myriad cellular organic and 
inorganic reactions. It is especially important in mitochondria, where approximately 95 % of 
cellular O2 is consumed by the ATP-generating process of oxidative phosphorylation [16, 238]. 
Mammalian cardiovascular systems have evolved to optimize O2 and substrate delivery to all 
cells of the body, achieving exacting yet flexible maintenance of homeostasis [239]. A literal 
powerhouse, the mature heart is one of the most metabolically active organs of the body, and a 
mitochondria-rich environment of extreme O2 handling. As such, it is especially vulnerable to 
conditions of low O2, or hypoxia, which is a central component of pathologies including cerebral 
and myocardial ischemia, chronic heart and lung diseases, inflammation and cancer [238, 240, 
241]. Hypoxia can result from both external and internal influences, including unbalanced 
ventilation/perfusion, over-paced metabolic demands, injury and immune responses [36]. It can 
also be highly localized – such as in a discrete cardiac injury from an occluded vessel; or can 
occur globally – such as in the system-wide impact of atherosclerosis. Thus, given its biological 
primacy and pathophysiological roles, it is unsurprising that tissue O2 homeostasis is tightly 
regulated by numerous, highly conserved cellular and systemic processes, some of which remain 
incompletely understood or even unknown [238, 241]. 
The presence of a phyletically ancient gene-based system to defend against changes in O2 
availability in multicellular eukaryotic aerobic organisms underscores the evolutionary priority of 
regulating O2 levels. Indeed, orthologues of the primary biochemical machinery for gene-based 
defenses against O2 deprivation – the hypoxia-inducible factor (HIF) transcription factors and 
their associated regulators – has been identified throughout the animal kingdom, suggesting that 
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HIF-inducible transcription first evolved as a cell-autonomous system to promote cell survival 
through induction of stress-response genes and altered cellular metabolism [239]. In mammals, 
HIFs are likewise recognized as critical mediators of the response to hypoxia, activating over 200 
genes encoding proteins that regulate cellular metabolism, proliferation, survival, motility and 
basement membrane integrity, as well as angiogenesis and hematopoiesis [185, 238, 242]. 
In mammals, hypoxia results in both acute and chronic adaptations. Rapid and reversible 
effects on cell signaling, contractility, ion flux and redox state balance energy supply and demand 
in the face of reduced capacity for oxidative metabolism. Whereas HIFs enable long-term cellular 
survival and vascular remodeling, a variety of HIF-independent pathways promote ATP 
conservation by limiting energy-consuming processes such as cell division, ribosome biogenesis, 
mRNA translation and ion channel activity. Indeed, it has been found that a rapid inhibition of 
protein synthesis, affected by means of a HIF-independent mechanism, is essential for cell 
survival during conditions of extreme hypoxia [16, 238]. 
Timely, appropriate responses to altered O2 tension depend on O2-sensing mechanisms at 
the ‘global’ (organism, organ) and ‘local’ (tissue, cell) levels, which monitor for very subtle 
changes in O2 levels and signal various protective responses. Indeed, several non-cell-specific O2-
sensing strategies have since been suggested. For instance, by virtue of its central role as 
integrator of O2 and fuel substrates, the mitochondrial electron transport chain may serve as O2-
sensing apparatus. During hypoxia, cytochrome c oxidase activity is suppressed due to substrate 
shortage, leading to electron leakage and the subsequent generation of ROS. These can then 
directly interact with effector proteins such as potassium channels and/or transcriptional factors 
such as HIF-1 [16]. As well, multiple O2-sensitive K+ channels have been identified that become 
inactivated upon hypoxia. These act opposite the voltage-gated, L-type calcium channels that, 
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when activated, serve to increase intracellular Ca2+. These K+ channels have since been found in 
virtually all O2-sensing tissues, including chemoreceptive carotid and neuroepithelial bodies 
[243], adrenal chromaffin cells [244] and pulmonary artery [245]. Moreover, hypoxic 
vasodilation has been proposed to result from hypoxia-responsive activation of KATP channels, 
providing further support for a central role for K+ channels in cardiovascular hypoxia. However, 
although these and other factors may be implicated in the response to low O2, they generally 
appear to be downstream of some other factor that couples hypoxia to the response itself [36]. 
From among the plethora of these and other proposed candidates, the gasotransmitters 
NO, CO and H2S have recently emerged as strong contenders. Such a role for NO and CO has 
previously been suggested due, in part, to the body’s use of small amounts of O2 as a substrate for 
their generation via NOS and HO, respectively. Put simply, this theory holds that as local O2 
concentrations decrease, so too does the activity of these reactionary pathways [16]. However 
plausible, these potential O2-sensing mechanisms remain largely unexplored. 
H2S’s inherent redox activities may alone have justified the exploration of this molecule 
as a putative O2-sensor, but recent findings offer other, more specific lines of evidence for an 
important role for H2S in O2-sensing in vascular smooth muscle. Upon initially noticing that the 
ex vivo vascular responses to hypoxia and H2S were similar, Olson et al. (2006) examined this 
potential relationship more closely and found that alteration of cellular H2S level served to 
modulate the vascular hypoxic response in animal models [246]. This led him to formulate a 
model for O2-sensing through the O2-dependent regulation of H2S metabolism. Here, H2S 
produced in the cytoplasm is constitutively oxidized in the mitochondria so long as O2 is readily 
available, and thus the cellular concentration of H2S should depend on the balance between H2S 
production and Po2. As such, intracellular H2S levels would remain comparatively low under 
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normoxic conditions, and increase proportionately to the severity of hypoxia. Indeed, in ex vivo 
lamprey, hagfish, rat and bovine vasotension models, hypoxia and H2S produced identical 
contraction, relaxation or multiphasic tonal responses [36, 46, 247]. However, the observed 
effects were noted only at very low Po2, and the type of tonal change, be it contraction or 
relaxation, was H2S concentration-dependent. Olson (2008) suggests that this dynamic feature of 
H2S may help to regulate pulmonary vasotension according to Po2, which is an important 
cardiorespiratory mechanism [36]. Recently, Olson et al. (2008) strengthened the argument that 
H2S metabolism might act as a general O2-sensor upon finding that, as in vascular tissues, H2S 
induced characteristic hypoxia responses in trout and zebrafish chemoreceptive tissues [248].   
Olson (2008) cites other corroborating, as well as confounding, evidence for O2-sensing 
through the O2-dependent regulation of H2S metabolism [36]. The evolutionary feasibility of a 
significant O2:H2S coupling is suggested by the molecules’ ancient relationships, including the 
constitutive production of H2S and its mitochondrial oxidation by O2 in the ancestors of all 
eukaryotic cells [36, 249, 250]. As well, the H2S-synthesizing enzymes CSE and CBS have been 
shown to be Po2 and redox-sensitive [251-253], which Olson (2008) suggests may either “directly 
contribute to intracellular H2S concentration or may provide a long-term mechanism to bias the 
rate of constitutive H2S production” [36]. Indeed, the recent finding that myocardial H2S 
production was inversely correlated with Po2 [254] suggests an autocrine or paracrine mechanism 
for the involvement of H2S/CSE in ischemic pre- [188, 189] and post-conditioning [196]. 
Moreover, this agrees with the recent evidence against appreciable circulating H2S levels [254]. 
Finally, as previously discussed, H2S is an established, ubiquitous signaling molecule with many 
known cytoprotective and modulatory roles in numerous systems, and certainly could, therefore, 
elicit physiological responses to hypoxia in a primary or secondary manner, such as via 
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stimulation of HIF-1-mediated signaling [255]. Taken together, these data strongly indicate that 
H2S metabolism may represent a reliable O2-sensing mechanism in many cells. If true, this 
further underscores the physiological primacy of H2S, especially in the highly O2-sensitive 
cardiovascular and neuronal systems, where H2S’s importance is already appreciated. 
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Objectives 
Project I - Hypoxic stress in CSE-deficient smooth muscle cells 
 
• Brief Rationale 
o Hypoxic stress is a ubiquitous feature of cardiovascular disease [13]. Recent 
findings suggest that H2S may act as a novel O2 sensor [256], and can regulate 
HIF-1 [255]. 
o Vasculoprotective roles for H2S have been well established in hypoxia-related 
vascular diseases including hypertension [99] and atherosclerosis [228]. 
o Mice genetically deficient in CSE expression exhibited increased blood pressure, 
decreased H2S level and compromised vasorelaxation [99]. Using SMCs isolated 
from this model, we have recently shown that over-proliferation of CSE-deficient 
SMCs contributes to the observed hypertension [94]. 
 
• Hypotheses 
o Given H2S’s roles in oxidative stress and inflammation in the vasculature, CSE-
deficient SMCs will exhibit increased mitochondrial activity, and unbalanced 
redox and inflammatory status versus their wild-type counterparts. 
o Given that deficient H2S/CSE pathway is implicated in the pathogenesis of 
hypertension and atherosclerosis, CSE-deficient SMCs will have a compromised 
hypoxia stress responsive capacity than their wild-type counterparts. 
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• Objectives 
o Measure and compare primary CSE-WT and -KO vascular SMCs under hypoxic 
stress in terms of: 
§  cell viability (via mitochondrial dehydrogenase activity and apoptosis),  
§ redox status (via superoxide dismutase activity and intracellular ROS),  
§ mitochondrial activity (via mitochondrial membrane potential),  
§ inflammatory status (via inflammatory cytokine expression), 
§ stress-responsive transcription (via HIF-1α expression). 
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Project II - CSE in simulated hypoxia and hypoxia-reoxygenation cardiac stress 
 
• Brief Rationale 
o H2S is a potent cardioprotectant, and has been shown to regulate redox balance 
and abrogate damage by preserving mitochondrial integrity	  [85]. Recent findings 
suggest that H2S has important relationships with O2 homeostasis	  [256] and HIF-1	  
[255]. 
o The hypoxia mimetic cobalt chloride (CoCl2) induces so-called ‘simulated 
hypoxia’ by activating HIF-1 under normoxic conditions, thereby inducing 
hypoxia stress responsive transcription. It has previously been shown to induce 
ROS elaboration and mitochondrial impairment in HL-1 cardiomyocytes	  [257]. 
o I-R injury is a major complicating feature of clinical disease entities including 
myocardial infarction and stroke [13]. Reperfusion imparts massive oxidative 
stress to cardiovascular tissues by generating high levels of ROS via the profound 
influx of O2 [185].   
 
• Hypotheses 
o Given the relevance of H2S’s cardioprotective effects and proposed HIF-1 
interaction to the mechanisms of action in CoCl2-induced ‘simulated hypoxia’, 
CoCl2 treatment of HL-1 cardiomyocytes is likely to engender H2S/CSE 
pathway involvement; inhibition of which should be detrimental to cell 
survival under CoCl2. 
o Given H2S’s cardioprotective role against I-R injury in vivo, hypoxia- 
reoxygenation (H-R) stress is likely to engender H2S/CSE pathway 
   
 56 
involvement in HL-1 cardiomyocytes; inhibition of which should be 
detrimental to cell survival under H-R stress. 
 
• Objectives 
o Establish HL-1 cardiomyocyte models of simulated hypoxic stress and H-R stress 
(via measurement of mitochondrial dehydrogenase activity and intracellular ROS 
levels).  
o Measure stress-induced CSE protein expression (via immunoblotting). 
o Inhibit CSE and measure viability (via mitochondrial dehydrogenase activity) to 
assess the contribution of H2S/CSE pathway to hypoxic cell survival. 
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Methods 
1.1 – CSE-deficient mouse model 
The CSE-deficient mouse model was developed by Dr. Rui Wang’s research group at the 
University of Saskatchewan. Readers are directed to their 2008 paper in the journal, Science, for a 
complete description of the methodology used in its generation [99]. 
 
1.2 – CSE-deficient vascular smooth muscle cells 
Single SMCs from mesenteric artery of CSE WT and CSE KO mice were isolated and 
identiﬁed as described previously [258]. These SMCs were cultured in Dulbecco’s modiﬁed 
Eagle’s medium containing 10 % supplemented foetal bovine serum (FBS), 100 U/mL penicillin, 
and 100 mg/mL streptomycin. The SMC identity was conﬁrmed by staining with SMC-speciﬁc a-
actin monoclonal antibody (Sigma, Oakville, ON, Canada), and the cells had the usual growth 
characteristics and at conﬂuence exhibited the typical ‘hill-and-valley’ pattern [258]. Cell counts 
and viabilities were assessed via automated Trypan Blue Exclusion assay using a Vi-Cell XR Cell 
Viability Analyzer (Beckman Coulter, Mississauga, ON, Canada; see below). Doubling time 
analysis was completed as per convention; generally, cells were maintained at a passage density 
of 1:3 to 1:6 depending on the intended usage. All experiments were completed when the cells 
reached 70-80 % conﬂuence with matched (i.e. same passage number for both WT and KO) 
cultures between passage 6 and 12. 
 
1.3 – Murine cardiomyocyte cell line 
The murine atrial cardiomyocyte (HL-1) cell line, obtained from the laboratory of Dr. 
William C. Claycomb, was cultured in gelatin/fibronectin (0.02 %) (Sigma)-coated Costar 0.2 
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µM vent cap cell culture flasks (Corning, Corning, NY, USA) in a specially formulated growth 
media (Claycomb Media, JRH Biosciences, Lenexa, KS, USA) supplemented with 10 % fetal 
bovine serum (FBS) (JRH Biosciences), L-glutamine (2 mM) (Invitrogen, Carlsbad, CA, USA), 
norepinephrine (100 µM) (Sigma), penicillin (100 U/ml), and streptomycin (100 µg/ml) 
(Invitrogen, Burlington, ON, Canada). All cardiomyocytes were cultured at 37 °C, 5 % CO2 and 
used for experimentation upon reaching approximately 95 % confluence. Cell counts and 
viabilities were assessed using a Vi-Cell XR Cell Viability Analyzer (Beckman Coulter; see 
below). Doubling time analysis was completed as per convention, and cultures were maintained 
according to this information in concert with the available instructions from Dr. Claycomb’s 
laboratory. HL-1 cells are derived from the murine atrial cardiomyocyte primary culture, AT-1. 
In contrast to AT-1 cells, HL-1 cells can be serially passaged, yet retain many characteristics of 
mature cardiomyocytes, although they are less differentiated, with less organized myofibrillar 
structure [259, 260]. Indeed, in the present studies, spontaneous contractions of the cells were 
neither induced nor observed. All experiments were completed with cultures between passage 51 
and 70. 
 
1.4 – Hypoxia chamber 
A humidified hypoxia glove box chamber with automatic controller (Coy, Grass Lake, 
MI, USA) was employed for the hypoxia phases of all treatment regimes, and set to 37 °C, 5 % 
CO2 and 1 % O2. A separate, interior, humidified tissue culture chamber was covered with 
aluminum foil to prevent photosensitive reactions with the cells and media. All interior surfaces 
were routinely sterilized via ethanol. Cell cultures were moved gently but rapidly to and from a 
second tissue culture incubator (~20 °C) via purgeable airlock during O2 treatment regimes. O2 
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levels did not fluctuate by more than 1 % O2 for more than 30 seconds during addition or removal 
of cell cultures from the chamber. 
 
1.5 – Cobalt chloride preparation 
CoCl2 (Sigma) was dissolved in ddH2O to produce 10 mM stock solutions that were 
stored at -20 °C in the absence of light. Stock solutions were used within 1 month and not 
refrozen. Sterile aliquots were added to serum-free culture media to form specific working 
treatment concentrations ranging from 50-500 µM. 
 
1.6 – D,L-propargylglycine preparation 
D,L-propargylglycine (PPG or PAG, Sigma) was dissolved in ddH2O to produce various 
stock solutions immediately prior to experiments. Sterile aliquots were added to serum-free 
culture media to form specific working treatment concentrations ranging from 100 µM to 10 mM. 
 
1.7 – Trypan Blue Exclusion assay 
The diazo dye, Trypan Blue ((3Z,3'Z)-3,3'-[(3,3'-dimethylbiphenyl-4,4'-
diyl)di(1Z)hydrazin-2-yl-1-ylidene]bis(5-amino-4-oxo-3,4-dihydronaphthalene-2,7-disulfonic 
acid), is a vital stain used to discern living from dead cells or tissues. It is cell-impermeable, 
penetrating only damaged, non-viable cells with compromised membrane integrity. Viable cell 
counts were performed via automated Trypan Blue Exclusion assay using a Vi-Cell XR Cell 
Viability Analyzer (Beckman Coulter), wherein 0.5 mL of diluted, trypsinized cell suspensions 
were loaded, mixed with Trypan Blue reagent, and live/dead cell counts assessed via 50 
individual sub-samples measured using the Vi-Cell XR Cell Viability Analyzer software. The 
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total viable cell count was used when passaging or standardizing cell samples for 
experimentation. Individual cell profiles for SMCs and HL-1 cardiomyocytes were created using 
the Vi-Cell XR Cell Viability Analyzer software to facilitate optimal cell counting accuracy. 
 
1.8 – MTT assay 
The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay is used as 
a quantitative index of activity of mitochondrial and cytosolic dehydrogenases, which, in living 
cells, reduce the yellow tetrazolium salt to produce a purple formazan dye that can be measured 
spectrophotometrically [261]. While typically described as measuring cell viability – particularly 
in toxicology and pharmacology studies – this assay is, by virtue of its test mechanism, more 
accurately described as a cell metabolism assay. Indeed, in the present studies the MTT assay was 
used to measure both cell viability and cell metabolism. Cells were seeded onto sterile flat-
bottom 96-well plates (Corning) and incubated overnight to achieve the desired confluence. 
Plated cells were subjected to chemical, hypoxic or normoxic pre- or co-treatment (various 
chemicals and conditions including CoCl2, PPG, 1 % O2, ~20 % O2, etc. at various concentrations 
in serum- and antibiotic-free media). With t = 4 hours of treatment time remaining, a suitable 
volume of MTT reagent (Thiazolyl Blue Tetrazolium Bromide; Sigma, St. Louis, MO, USA) was 
added to wells to achieve a final concentration of 10 % (v/v), and cells were incubated at 37 °C 
for an additional 4 hours, during which time the MTT reagent was converted to purple formazan 
crystals in living cells according to their metabolic activity. Following this, the incubation media 
was aspirated and 50 µL of dimethylsulfoxide per well was added to solubilise the formazan 
crystals. Following 10 minutes of agitation on a Belly Dancer shaker (Stovall, Greensboro, NC, 
USA) at its highest setting, absorbance was measured spectrophotometrically at a wavelength of 
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490 nm (650 nm correction wavelength) using a PowerWave XS Microplate Spectrophotometer 
(BioTek, Winooski, VT, USA). Viability of treated wells was assessed relative to control wells, 
which were considered to represent 100 % viability. Note that in early HL-1 cell experiments, 
samples were cultured in all columns and rows of the 96-well plates. However, upon observing a 
distinct difference in absorbance in the wells around the perimeter of the plate (i.e. rows 1 and 8, 
columns 1 and 12) – the so-called ‘edge effects’ – this practice was stopped, and existing data 
was revisited to correct the operator error. 
 
1.9 – Reactive oxygen species indicator assay 
CM-H2DCFDA (5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate, 
acetyl ester) is used as a cell-permeable indicator of ROS. This molecule remains non-fluorescent 
until the acetate groups are removed by intracellular esterases as oxidation occurs within the cell. 
In addition, esterase cleavage of the lipophilic blocking groups yields a charged form of the dye 
that is much better retained by cells than the parent compound. Moreover, the chloromethyl 
derivative of H2DCFDA used here allows for covalent binding to intracellular components, 
permitting even longer retention within the cell. Cells were seeded onto sterile flat-bottom 6-well 
plates (Corning) and grown overnight to achieve the desired confluence. Plated cells were 
subjected to various time periods of chemical, hypoxic or normoxic pre- or co-treatment (various 
chemicals and conditions including CoCl2, PPG, 1 % O2, ~20 % O2, etc. at various concentrations 
in serum- and antibiotic-free media). The previously optimized, so-called ‘snapshot’ method of 
CM-H2DCFDA loading was employed, facilitating better insight into the present redox status, as 
opposed to the more cumulative measure afforded by pre-loading of cells with label. Following 
challenge, cells were washed with PBS and stained for 30 minutes with CM-H2DCFDA 
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(Molecular Probes, Eugene, OR, USA) under standard incubation conditions (even for hypoxia-
only treatment samples). Stained cells were washed with PBS and either detached from the plate 
surface using either trypsin or disposable sterile cell scrapers (Fisher Scientific) and suspended in 
PBS for flow cytometric analysis using the FL1-H channel of a BD FACSCalibur Flow 
Cytometer (BD Biosciences) supported by BD CellQuest Pro Software. A minimum of 1 x 104 
gated events were acquired per trial. Mean fluorescence (specifically: geometric mean 
fluorescence) was understood to be directly proportional to levels of intracellular ROS. In early 
experiments, a H2O2 control was also analyzed to aid in calibrating the flow cytometer for this 
assay. 
 
1.10 – Phosphatidylserine residue-based apoptosis detection assay 
In normal, viable cells, phosphatidylserine (PS) is located on the cytoplasmic surface of 
the cell membrane, but becomes translocated from the inner to the outer leaflet in during 
apoptosis [262]. The human vascular anticoagulant, annexin V, is a 35-36 kD Ca2+-dependent 
phospholipid-binding protein that possesses a high affinity for PS. Thus, fluorophore-labeled 
annexin V can be used to identify apoptotic cells by virtue of its binding to PS on the outer 
leaflet. However, because annexin V conjugates are able to pass through the compromised 
membranes of necrotic cells and bind to PS in the interior of the cell, propidium iodide (PI), a live 
and early apoptotic cell-impermeable (necrotic cell) stain that binds to DNA, is used in 
combination with annexin V staining to distinguish necrotic from apoptotic cells.  
PS translocation was assessed via flow cytometric analysis of control and treated cells that 
were dually stained with annexin V and PI using the Annexin V-FITC Apoptosis Detection kit 
(Sigma). Cells were seeded onto sterile flat-bottom 25 cm2 culture flasks (Corning) and grown 
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overnight to achieve the desired confluence. Plated cells were subjected to various time periods 
of chemical, hypoxic or normoxic pre- or co-treatment (various chemicals and conditions 
including CoCl2, PPG, 1 % O2, ~20 % O2, etc. at various concentrations in serum- and antibiotic-
free media). Following challenge, cells were washed with PBS and suspended via trypsinization 
in 100 µL annexin-binding buffer at 1 x 106 cells / mL. Cells were then incubated at room 
temperature with annexin V-FITC and/or PI stain in the absence of light. Following 15 minute 
incubation, single- and dual-stained samples were diluted with 400 µL annexin-binding buffer 
and immediately analyzed via flow cytometry with a BD FACSCalibur Flow Cytometer (BD 
Biosciences) supported by BD CellQuest Pro Software on the FL1-H (ANX) and FL2-H (PI) 
channels, acquiring a minimum of 1 x 104 gated events per trial. ANX-/ PI- cells were considered 
be to living, ANX+/ PI- cells apoptotic, and ANX+/-/ PI+ cells necrotic. 
 
1.11 – Active caspases 3/7-based apoptosis detection assay 
The central component of the apoptotic process is a cascade of proteolytic enzymes called 
caspases, which participate in a series of reactions triggered in response to pro-apoptotic signals 
that result in the cleavage of protein substrates, causing the disassembly of the cell [263]. A cell-
permeable, carboxyfluorescein-labeled fluoromethyl ketone peptide inhibitor, fluorochrome 
inhibitors of caspases (FLICA), covalently binds to a reactive cysteine residue that resides on the 
large subunit of the active caspase heterodimer, thereby inhibiting further enzymatic activity. The 
bound labeled reagent is retained within the cell, while any unbound reagent will diffuse out of 
the cell and is washed away. The green fluorescent signal is a direct measure of the amount of 
active caspase-3 or caspase-7 present in the cell at the time the reagent was added. Active 
caspase-3/7 activity was assessed via flow cytometric analysis of control and treated cells that 
   
 64 
were dually stained with FLICA and PI using the CaspaTag Caspase-3/7 In Situ Assay kit 
(Chemicon International, Temecula, CA, USA). Cells were seeded onto sterile flat-bottom 25 cm2 
culture flasks (Corning) and grown overnight to achieve the desired confluence. Plated cells were 
subjected to various time periods of chemical, hypoxic or normoxic pre- or co-treatment (various 
chemicals and conditions including CoCl2, PPG, 1 % O2, ~20 % O2, etc. at various concentrations 
in serum- and antibiotic-free media). Following challenge, cells were washed with wash buffer 
and suspended via trypsinization in PBS to achieve 1 x 107 cells / mL. 10 µL of freshly prepared 
FLICA reagent was added to 290 µL of cell suspension, mixed gently and incubated at 37 °C for 
1 hour in the absence of light (mixing gently twice during this incubation). Following several 
wash and count steps, samples were immediately analyzed via flow cytometry with a BD 
FACSCalibur Flow Cytometer (BD Biosciences) supported by BD CellQuest Pro Software on the 
FL1-H (FLICA) and FL2-H (PI) channels, acquiring a minimum of 1 x 104 gated events per trial. 
FLICA-/PI- cells were considered be to living, FLICA+/ PI- cells apoptotic, and FLICA+/PI+ 
cells necrotic. 
 
1.12 – Mitochondrial membrane potential assay 
The heart is dependent upon adequate O2 delivery for normal function, as it derives most 
of its metabolic energy from oxidative phosphorylation. The mitochondrial proton gradient, of 
which mitochondrial membrane potential (Ψm) forms by far the largest part, is the most direct 
measure of the state of energization of the mitochondria [264]. Indeed, although often 
approximated via measurement of adenine phosphorylation potential (i.e. adenosine triphosphate 
ATP), creatinine, or inorganic phosphate), this can be a poor surrogate given that ATP content 
and mitochondrial respiration have been shown to be clearly out of step during ischemia-
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reperfusion [265]. The carbocyanine derivative, JC-1 (5,5',6,6'-tetrachloro-1,1',3,3'-tetraethyl-
benzimidazolylcarbocyanineiodide), is a cationic dye that exhibits potential-dependent 
accumulation in mitochondria and a corresponding conversion from monomer to J-aggregate 
evidenced by a shift in emitted light upon excitation at 490 nm [266], thereby facilitating 
measurement of Ψm. 
Ψm was assessed using the MitoProbe JC-1 Assay Kit for Flow Cytometry (Molecular 
Probes). Cells were seeded onto sterile flat-bottom 6-well plates (Corning) and grown overnight 
to achieve the desired confluence. Plated cells were subjected to various time periods of 
chemical, hypoxic or normoxic pre- or co-treatment (various chemicals and conditions including 
CoCl2, PPG, 1 % O2, ~20 % O2, etc. at various concentrations in serum- and antibiotic-free 
media). Following challenge, cells were washed with PBS and stained for 30 minutes with JC-1. 
Stained cells were then detached from the plate surface via trypsinization and suspended in PBS 
for flow cytometric analysis using the FL1-H (monomer) and FL2-H (aggregate) channels of a 
BD FACSCalibur Flow Cytometer (BD Biosciences) supported by BD CellQuest Pro Software. 
A minimum of 1 x 104 gated events were acquired per trial. The ratio of red fluorescence 
(potential-dependent generation of J-aggregates) to green fluorescence was used, as per 
convention, to describe the relative status of mitochondrial electric potential, wherein high ratio 
indicated high potential and, thus, mitochondrial activity, and low ratio indicated low potential 
and, thus, compromised and/or low mitochondrial activity. 
 
1.13 – Superoxide dismutase activity assay 
The production of superoxide radicals is a substantial contributor, if not the primary 
cause, of ischemia reperfusion injury [267]. Superoxide dismutases (SODs) catalyze the 
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dismutation of the superoxide radical (O2-) into H2O2 and elemental oxygen (O2) which diffuses 
into the intermembrane space or mitochondrial matrix, providing an important defense against the 
toxicity of superoxide radicals [268]. Indeed, given its major contribution to total antioxidant 
capacity, measurement of SOD provides excellent general insight into cellular redox status. In the 
Superoxide Dismutase Assay (Trevigen, Helgerman Ct. Gaithersburg, MD, USA), ions generated 
from the conversion of xanthine to uric acid and H2O2 by xanthine oxidase, converts nitro-blue 
tetrazolium chloride (NBT) to NBT-diformazan, which absorbs light at 550 nm. SOD reduces 
superoxide ion concentrations, thereby lowering the rate of NBT-diformazan formation, which 
can thus be used to measure the SOD activity present in an experimental sample [269]. 
Cells were seeded onto sterile 150 cm2 culture flasks (Corning) and grown overnight to 
achieve the desired confluence. Plated cells were subjected to various time periods of chemical, 
hypoxic or normoxic pre- or co-treatment (various chemicals and conditions including CoCl2, 
PPG, 1 % O2, ~20 % O2, etc. at various concentrations in serum- and antibiotic-free media). 
Immediately following challenge, pelleted cell samples were lysed and their total protein 
quantitated via DC Protein Assay (Bio-Rad), being careful to keep protein samples cold to 
prevent degradation. Samples were assayed as per the kit’s instructions and absorbance read at 
550 nm using a PharmaSpec UV-1700 Visible Spectrophotometer (Shimadzu, Columbia, MD, 
USA). The extent of SOD activity was gleaned from calculating absorbance at 330 seconds 
subtracted by absorbance at 30 seconds, where greater SOD activity would be evidenced by less 
change in absorbance over time. These values were converted to units SOD per volume by 
reference to an SOD inhibition curve, generated as per the kit’s instructions.  
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1.14 – Radioimmunoprecipitation assay 
Cell samples for use in immunoblotting were lysed via modified 
radioimmunoprecipitation assay (RIPA), a strongly denaturing lysis buffer due to its ionic 
detergents, sodium dodecyl sulfate (SDS) and sodium deoxycholate. This lysis buffer and 
protocol was based on that previously used for HL-1 cardiomyocytes [270], but included also the 
protease inhibitors, phenylmethylsulfonyl fluoride, leupeptin, aprotinin, pepstatin, and 
phosphatase inhibitors, sodium fluoride and activated sodium orthovanadate. These inhibitors 
were prepared in ddH2O or ethanol and stored at -20 °C. Inhibitors were added immediately prior 
to RIPA buffer application, and aliquots were not refrozen to ensure their activity. Upon addition 
of ice-cold lysis buffer to pelleted cell samples, the crude lysate was pipetted up and down 
repeatedly using a chilled pipette tip, then passed through a chilled syringe to further degrade the 
cellular structures. Lysates were vortexed, incubated on ice for 10 minutes, vortexed again and 
incubated on ice for a further 10 minutes. Lysates were then centrifuged for 12 minutes at 1 x 104 
rpm to remove cellular debris. Supernatant was collected and stored at - 80 °C and/or kept on ice 
for immediate quantitation. All protein lysis and sample handling was completed at a cold-room 
bench at 4 °C, and all tubes and equipment were pre-cooled. 
 
1.15 – Total protein assay 
Protein lysates were quantitated via a detergent-compatible, colourimetric, Lowry-based 
protein assay. Using the DC Protein Assay (Bio-Rad)’s ‘microplate’ method, which requires only 
small (5 µL) quantities of protein lysate, full-strength and 1/10-strength samples were measured 
alongside a range of bovine serum albumin (BSA; Fisher) standard concentrations from 0.2-1.5 
mg / mL. Following a 15-minute colour-development period, standard and sample absorbance 
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was measured spectrophotometrically at a wavelength of 750 nm using a PowerWave XS 
Microplate Spectrophotometer (BioTek). Microsoft Excel for Macintosh was used to create a 
standard curve from the BSA standards, and the equation of the line of best fit (minimum 
accepted R2 = 0.99) was used to calculate the sample protein concentrations. Stock sample lysates 
were kept on ice to minimize degradation during the course of the assay. 
 
1.16 – Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
Immediately following quantitation, 6x Laemmli sample loading buffer containing ß-
mercaptoethanol (Sigma-Aldrich) or dithiothreitol (Sigma) was added to the sample lysates, 
which were then placed in a 100 °C water bath for 5 minutes (with punctured tube lids to alleviate 
pressure). Boiled lysates were quick-spun and either stored at -80 °C for future use or loaded into 
12 % sodium dodecyl sulfate-polyacrylamide gels at ~10-50 µg per well (Bio-Rad Mini 
PROTEAN 3 Cell System apparatus was used). 10-15 µL (equivalent to 10-15 µg) of HiMark™ 
Pre-stained protein standard (Invitrogen) or Precision Plus Kaleidoscope (Bio-Rad) protein 
standard was loaded alongside the sample wells. Empty wells were partially filled with 1x 
Laemmli sample loading buffer to ensure even migration across the gel (first and last columns 
left empty save for sample loading buffer due to poorer polymerization). The electrophoresis 
apparatus was filled with 1x Running buffer (standard Laemmli 1x Running buffer was prepared 
from a 10x stock). Gels were run at 100 V for 20 minutes or until the sample front cleared the 
stacking gel, followed by 150 V until the appropriate kDa range had migrated to the centre of the 
resolving gel, as indicated by reference to the protein standard indicator. 
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1.17 – Electrophoretic transfer 
Immediately upon completion of sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (to prevent protein band dissociation), gels were removed from the 
electrophoresis assembly, their edges trimmed and orientation marks added (i.e. diagonal edge 
cut at top-left), and then were soaked in ice-cold 1x Transfer buffer for ~15 minutes for 
equilibration (standard Laemmli 1x transfer buffer was prepared from a 10x stock). 
Polyvinylidene fluoride transfer membrane (Pierce, Rockford, IL, USA) was soaked in methanol 
for no more than 30 seconds before rinsing with ddH2O. The transfer cassette was assembled as 
per the manufacturer’s instructions, filled with ice-cold 1x Transfer buffer, and the transfer was 
performed at either 100 V for 1 hour or at 25-30 V for 8-16 hours at 4 °C, with ddH2O ice blocks 
and rapid, magnetic-stirrer buffer agitation. 
 
1.18 – Protein immunoblot and antibodies 
Following electrophoretic transfer, gels were soaked in Coomassie Blue dye (Sigma) on a 
rocker for at least 1 hour and then soaked in de-stain solution while actively monitored to verify 
successful protein transfer (i.e. insubstantial Coomassie Blue staining of the gels). Membranes 
were stained with Ponceau S solution (Bio-Rad) for 5-10 minutes to further verify transfer 
efficiency (i.e. substantial Ponceau S staining of the membranes), and Ponceau S stain was 
removed by successive washes in ddH2O. The membranes were then soaked in Tris-buffered 
saline containing 0.1 % Tween-20 detergent (TBST) (Sigma) for ~15 minutes (protein side up) to 
wash and equilibrate them before being blocked with 5 % milk in TBST solution for 2 hours at 
room temperature or 8-16 hours at 4 °C.  
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Blocked membranes were briefly rinsed in TBST before incubation with 1:1000 CSE 
polyclonal primary antibody in 5 % milk / TBST for 2 hours at room temperature on a Belly 
Dancer shaker (Stovall) set to low agitation. The CSE antibody was produced by Dr. Rui Wang’s 
University of Saskatchewan laboratory and directly provided by Dr. Guangdong Yang). 
Membranes were then washed in TBST on a vigorous rocker for 1 hour, changing the wash 
solution every 10 minutes.  Following this step, 1:5000 HRP-conjugated goat anti-rabbit IgG 
secondary antibodies (Pierce) in 5 % milk / TBST solution were used to probe the membrane on a 
rocker for 45-60 minutes at room temperature.  Following this step, membranes were again 
washed with TBST on a vigorous rocker for 1 hour, changing the wash solution every 10 
minutes.  
Following chemiluminescent imaging (below), membranes were stripped for re-blotting 
with the protein standard, 1:2000 β-actin monoclonal primary antibody (Novus, Littleton, CO, 
USA). A ‘medium’ strength stripping buffer, containing SDS, was required to sufficiently 
remove antibodies from the membranes. In initial experiments, the CSE primary antibody 
detected a ~100 kDa, non-specific product. However, via a combination of increasing the protein 
sample concentration, cutting gels below the 100 kDa range (via the visible, multi-colourimetric 
protein ladder) and overexposing the chemiluminescent blot images, the appropriate, ~ 44.5 kDa 
CSE product could be clearly discerned in HL-1 cardiomyocyte lysates. 
 
1.19 – Chemiluminescent imaging and densitometry 
Enhanced chemiluminescence (ECL) utilizes horseradish peroxidase enzyme (HRP) 
tethered to the molecule of interest (usually through labeling an immunoglobulin that specifically 
recognizes the molecule). This enzyme complex then catalyzes the conversion of the ECL 
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substrate into a sensitized reagent in the vicinity of the molecule of interest, which on further 
oxidation by H2O2, produces a triplet (excited) carbonyl which emits light when it decays to the 
singlet carbonyl. Standard ECL was performed to detect protein-banding patterns on the 
immunoblots by virtue of the HRP-conjugated secondary antibodies (above). Chemiluminescent 
immunoblots were detected via 10-minute High-Sensitivity Chemiluminescent exposures using a 
Chemidoc XRS imager (Bio-Rad) supported by Quantity One software for Windows (Bio-Rad). 
Brief Epi-White exposures were also collected in order to interpret chemiluminescent banding 
patterns vis-à-vis the membranes’ visible protein ladders. Blots were analyzed via densitometry 
using the Quanity One software, with reference to the re-probed β-actin control. 
 
1.20 – RNA isolation 
RNA isolation was performed using the Aurum Total RNA Mini kit (Bio-Rad) in 
accordance with the manufacturer’s instructions using certified RNase-free barrier tips (Ambion, 
Foster City, CA, USA). Cells were seeded onto sterile 25 cm2 culture flasks (Corning) and grown 
overnight to achieve the desired confluence. Plated cells were subjected to various time periods 
of chemical, hypoxic or normoxic pre- or co-treatment (various chemicals and conditions 
including CoCl2, PPG, 1 % O2, ~20 % O2, etc. at various concentrations in serum- and antibiotic-
free media). Adherent cells were washed once with PBS and detached via trypsinization. 
Following centrifugation (500 × g for 5 min at 4 ˚C), cells were washed with PBS and lysed using 
the provided lysis and binding buffer containing chaotropic components for stabilization of RNA 
and inhibition of RNase activity. Lysates were placed in RNAse-free microfuge tubes (Ambion) 
and RNA was extracted using a silica membrane spin column. Upon loading the RNA onto the 
column, genomic DNA was digested with an RNase-free DNase enzyme and, following washes 
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to remove degraded genomic DNA, salts, and other cellular components, an elution buffer of low 
ionic strength was used to collect the pure RNA from the column. Aliquots were stored at -80 ˚C 
unless being used immediately, in which case they were kept on ice and separated into stock and 
sample aliquots, the latter used for RNA quantitation. 
 
1.21 – Automated electrophoretic RNA analysis 
The concentration and integrity of extracted RNA was assessed using the Experion RNA 
StdSens kit (Bio-Rad) on an Experion Automated Electrophoresis Station (Bio-Rad) supported by 
Experion software for Windows (Bio-Rad), in accordance with the manufacturer’s instructions. 
Briefly, 1 µL aliquots of denatured RNA samples and ladder were loaded onto a microfluidic chip 
comprised of channels that, once primed with a gel matrix, allowed for the separation, staining, 
detection, and data analysis of samples by via measurement of the 18 and 28 S rRNA peaks. Only 
high-quality (i.e. 9+ RNA quality index, as per automatic Experion software calculation) RNA 
samples were used for subsequent gene expression analysis. 
 
1.22 – cDNA synthesis 
First strand complementary DNA (cDNA) synthesis reactions were performed using a 
RevertAid H Minus First Strand cDNA Synthesis kit (Fermentas, Flamborough, ON, Canada) in 
accordance with the manufacturer’s instructions. This kit features reverse transcriptase with a 
point mutation that completely eliminates RNase H activity and, in concert with the kit’s RNase 
inhibitor, helps prevent RNA degradation during cDNA synthesis. Briefly, RNA samples were 
mixed with oligo(dT)18 primers and the other kit components and incubated at 42 ˚C for 1 hour 
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before terminating the reaction by heating at 70 ˚C for 5 minutes. The resultant products were 
stored at -20 ˚C unless being used immediately, in which case they were kept on ice. 
 
1.23 – Quantitative real-time polymerase chain reaction 
Quantitative real-time PCR (qPCR) was performed using primers for various genes 
(SABiosciences, Frederick, MD, USA) and SYBR Green RT2 qPCR Master Mix 
(SABiosciences) via iQ5 Multicolor Real-Time PCR Detection System (Bio-Rad) in accordance 
with the manufacturer’s instructions. Briefly, 10 µL of 2x Master Mix was pipetted into the wells 
of a sterile 96-well PCR plate (Bio-Rad). Primer was added to nuclease-free ddH2O at a ratio of 1 
µL primer to 8 µL ddH2O, and then 9 µL of the mix was pipetted into the wells of the PCR plate, 
followed by 1 µL cDNA template. The PCR plate was sealed with optical film (Bio-Rad). 
Following iQ5 calibration, qPCR analysis of triplicate samples was performed using a two-step 
cycling program involving an initial single cycle of 95 ˚C for 10 min (required to activate the 
DNA polymerase), followed by 40 cycles of 95 ˚C for 15 seconds and 60 ˚C for 1 minute. 
Following the qPCR reaction, a first derivative dissociation curve was performed as a quality 
control measure. Briefly, the reaction was heated to 95 ˚C for 1 min, cooled to 65 ˚C for 2 min, 
then ramped from 65 to 95 ˚C at a rate of 2 ˚C per minute. The formation of a single peak at 
temperatures greater than 80 ˚C indicated the presence of a single PCR product in the reaction 
mixture. Gene of interest expression was normalized to the housekeeping gene, β2-microglobulin, 
which was found to be most consistent as compared to either β-actin or GAPDH. 
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Gene name UniGene # RefSeq  
Accession # 
Band Size  
(bp) 
Reference Position Source 
Tumour necrosis factor-α Mm.1293 NM_013693 93 879 SABiosciences 
Interferon-γ Mm.240327 NM_008337 95 330 SABiosciences 
Interleukin-10 Mm.874 NM_010548 110 1005 SABiosciences 
Transforming growth factor-β Mm.248380 NM_011577 162 267 SABiosciences 
Hypoxia inducible factor-α Mm.3879 NM_010431 151 3633 SABiosciences 
Β2-microglobulin Mm.163 NM_009735 192 304 SABiosciences 
 
Table 1. Quantitative real-time PCR primers. These primer sets were used as per manufacturer’s instructions, as 
described above. 
 
1.24 – Statistics 
Data were presented as mean ± standard error of the mean (SEM), and all data presented 
here represents n ≥ 3 independent experiments. Statistical analyses were performed using 
GraphPad Prism software. One-way ANOVA with post hoc Tukey’s test were utilized when 
possible, and the Student’s t-test used otherwise, with p < 0.05 considered significant. Asterisks 
are used herein to denote significance according to the following scheme: * = p < 0.05; ** = p < 
0.01; *** = p < 0.001. 
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Results 
Project I - Hypoxic stress in CSE-deficient smooth muscle cells 
 
Basal metabolic activity, intracellular ROS and Ψm in CSE WT and KO SMCs 
Given the significant differences we had previously observed between the CSE-deficient 
mouse model-derived wild-type (WT) and knockout (KO) SMCs [94], their further 
characterization was of great interest and relevance. Thus were undertaken comparative 
assessments of cellular metabolism, ROS levels and Ψm, via the colourimetric MTT assay and the 
fluorescent CM-H2DCFDA (using the ‘snapshot’ method) and JC-1 assays, respectively. Under 
basal conditions (24 hours serum- and antiobiotic-free media, but no additional stressor), KO 
cells featured significantly higher metabolic activity (+27 %, p < 0.001; Figure 4), intracellular 
ROS levels (+127 %, p < 0.001; Figure 5) and Ψm (+62 %, p < 0.05; Figure 6) versus their WT 
counterparts. 
 
Effect of hypoxia on CSE WT and KO SMC cell viability and apoptosis 
Following consideration of the available literature, and in an effort to produce conditions 
that would approximate the in vivo situation for SMCs experiencing pathophysiologically 
relevant hypoxia, SMCs were subjected to a hypoxia regimen of 12 hours at 1 % O2 (via hypoxic 
tissue culture chamber). Cell viability/metabolic activity was assessed via the colourimetric MTT 
assay, wherein MTT reagent was added to cultures at t = 8 hours and incubated for the remaining 
4 hours of hypoxia before analysis at t = 12 hours. Whereas 12-hour hypoxia-induced KO cell 
viability was significantly decreased (-61 %, p < 0.001; Figure 7), WT viability was not. 
Apoptosis was assessed via the fluorescent CaspaTag 3/7 assay, with analysis via flow cytometry. 
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Hypoxia induced greater apoptosis in KO (+85 %, p < 0.001; Figure 8) than in WT cells (+23 %, 
p < 0.05; Figure 8). Given that the extent of the hypoxia-induced changes in apoptosis was 
deemed to be within a reasonable, physiologically relevant range, the present hypoxia protocol 
was retained for subsequent experiments.  
 
Effect of hypoxia on CSE WT and KO SMC redox balance and Ψm  
In order to investigate the underlying factors to the observed hypoxia-induced SMC death, 
and to ascertain whether the redox and Ψm differences between WT and KO cells noted under 
basal conditions were also present upon hypoxic insult, redox status and mitochondrial membrane 
potential were assessed via the colourimetric SOD activity assay and the fluorescent CM-
H2DCFDA and JC-1 assays, with analysis via flow cytometry. 12-hour hypoxia induced similarly 
modest but significant increases in SOD content in WT (+9 %, p < 0.05) and KO cells (+9 %, p < 
0.05; Figure 9). Despite this parity, intracellular ROS was significantly increased in hypoxic KO 
(+75 %, p < 0.001; Figure 10) but not WT cells. Ψm was not significantly impacted by hypoxia, 
but, as was the case under basal conditions, the absolute Ψm values remained significantly higher 
in KO (+118 %, p < 0.01; Figure 11) versus WT cells.  
 
Effect of hypoxia on CSE WT and KO SMC inflammatory mediator expression 
Given the observed redox imbalance, and the known relationship of pro-oxidant and pro-
inflammatory status in cardiovascular disease, assessment of the mRNA expression of several 
inflammatory mediators – TNF-α, IFN-γ, IL-10 and TGF-β – was undertaken via qPCR, with 
normalization via β2M. Under basal conditions, KO cells featured significantly lower expression 
of TNF-α (-80 %, p < 0.001; Figure 12) and IFN-γ (-43 %, p < 0.001; Figure 13), and 
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significantly higher expression of IL-10 (+483 %, p < 0.001; Figure 14) and TGF-β (+194 %, p 
< 0.001; Figure 15). 
Upon 12-hour hypoxic insult, TNF-α expression was significantly decreased in WT (-94 
%, p < 0.001; Figure 12) but not KO cells. IFN-γ expression was decreased in WT (-28 %, p < 
0.05; Figure 13) but substantially increased in KO cells (+259 %, p < 0.001; Figure 13). IL-10 
expression was massively increased in WT (+412 %, p < 0.001; Figure 14) but substantially 
decreased in KO cells (-73 %, p < 0.001; Figure 14). TGF-β expression was increased in KO 
cells (+64 %, p < 0.001) but massively increased in WT cells (+319 %, p < 0.001; Figure 15). 
 
Effect of hypoxia on CSE WT and KO SMC HIF-1α expression 
Given the patently poorer ability of the CSE-deficient SMCs to respond to hypoxic stress, 
and in light of the established role of master transcriptional regulator, hypoxia inducible factor 
(HIF)-1, to promote the cellular hypoxic stress response, an assessment of the mRNA expression 
of its O2-sensitive alpha subunit, HIF-1α, was undertaken via qPCR, with normalization via β2M. 
12-hour hypoxia induced increased HIF-1α expression in KO cells (+138 %, p < 0.001), but a 
greater increase in expression in WT cells (+258 %, p < 0.001; Figure 16). 
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Figure 4. Basal metabolic activity in CSE-WT and -KO SMCs. Basal metabolic activity of CSE-WT 
and -KO SMCs was assessed via colourimetric measurement of mitochondrial dehydrogenase activity 
(MTT assay). Matched passage WT and KO cells were seeded onto 96-well plates, grown overnight to 70-
80 % confluence, and incubated in serum- and antibiotic-free medium for 12 hours.  MTT reagent was 
added at t = 8 hours and absorbance was measured spectrophotometrically at 490 nm (650 nm correction 
wavelength) at t = 12 hours. Normal viability was standardized to the normoxic WT condition. Bars 
represent mean ± SEM of 3 independent experiments. *** denotes significance of p < 0.001. 
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Figure 5. Basal intracellular ROS levels in CSE-WT and -KO SMCs. Basal intracellular ROS levels in 
CSE-WT and -KO SMCs was assessed via fluorescent detection of oxidation-induced esterase activity 
(CM-H2DCFDA assay), and analyzed via flow cytometry. Matched passage WT and KO cells were 
seeded onto 6-well plates, grown overnight to 70-80 % confluence, and incubated in serum- and antibiotic-
free medium for 12 hours.  The ‘snapshot’ method was utilized, whereby cells were incubated with 
fluorescent label for 30 minutes post hypoxic stress in order to ascertain the final redox environment of the 
cells, and a minimum of 1 x 104 gated events were analyzed via flow cytometry. Bars represent mean ± 
SEM of 3 independent experiments. *** denotes significance of p < 0.001. 
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Figure 6. Basal Ψm in CSE-WT and -KO SMCs. Basal Ψm of CSE-WT and -KO SMCs was assessed via 
the fluorescent detection of potential-dependent incorporation and conversion of a cationic dye (JC-1 
assay), and analyzed via flow cytometry. Matched passage WT and KO cells were seeded onto 6-well 
plates, grown overnight to 70-80 % confluence, and incubated in serum- and antibiotic-free medium for 12 
hours. Cells were incubated with fluorescent label for 30 minutes, and a minimum of 1 x 104 gated events 
were analyzed via flow cytometry, wherein the ratio of red to green fluorescence indicated mitochondrial 
polarization status (where increased conversion of the green fluorescent label to red, and thus a higher 
fluorescence ratio, indicated greater depolarization). Bars represent mean ± SEM of 3 independent 
experiments. * denotes significance of p < 0.05. 
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Figure 7. Effect of hypoxic stress on viability of CSE-WT and -KO SMCs. The effect of hypoxic stress 
on the viability of CSE-WT and -KO SMCs was assessed via measurement of mitochondrial 
dehydrogenase activity (MTT assay). Matched passage WT and KO cells were seeded onto 96-well plates, 
grown overnight to 70-80 % confluence, and incubated in serum- and antibiotic-free medium in a hypoxia 
chamber at 1 % O2 for 12 hours.  MTT reagent was added at t = 8 hours and absorbance was measured 
spectrophotometrically at 490 nm (650 nm correction wavelength) at t = 12 hours. Normal viability was 
standardized to the normoxic WT condition. Bars represent mean ± SEM of 3 independent experiments. 
Connected lines indicate relationship; * denotes significance of p < 0.05; *** denotes significance of p < 
0.001. 
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Figure 8. Effect of hypoxic stress on CSE-WT and -KO SMC apoptosis. The effect of hypoxic stress 
on CSE-WT and -KO SMC apoptosis was assessed via the fluorescent detection of active caspase-3 and -7 
(CaspaTag 3/7 assay), and analyzed via flow cytometry. Matched passage WT and KO cells were seeded 
onto 25 cm2 tissue culture flasks, grown overnight to 70-80 % confluence, and incubated in serum- and 
antibiotic-free medium in a hypoxia chamber at 1 % O2 for 12 hours. Cells were incubated with 
fluorescent FLuorochrome Inhibitors of CAspases (FLICA) and/or propidium iodide (PI) labels for 15 
minutes, and a minimum of 1 x 104 gated events were analyzed via flow cytometry, with PI-positive 
staining subtracted from FLICA-positive staining to control for necrosis, thereby specifying for apoptotic 
cells. Bars represent mean ± SEM of 3 independent experiments. Connected lines indicate relationship; * 
denotes significance of p < 0.05; *** denotes significance of p < 0.001. 
   
 83 
 
Figure 9. Effect of hypoxic stress on SOD activity in CSE-WT and -KO SMCs. The effect of hypoxic 
stress on SOD activity in CSE-WT and -KO SMCs was assessed via a colourimetric SOD activity assay. 
Matched passage WT and KO cells were seeded onto 150 cm2 tissue culture flasks, grown overnight to 70-
80 % confluence, and incubated in serum- and antibiotic-free medium in a hypoxia chamber at 1 % O2 for 
12 hours. Sample cell lysates were quantitated and assayed via measurement over time of absorbance at 
550 nm. SOD activity was converted to units SOD per volume by reference to an SOD inhibition curve. 
Bars represent mean ± SEM of 3 independent experiments. Connected lines indicate relationship; * 
denotes significance of p < 0.05. 
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Figure 10. Effect of hypoxic stress on intracellular ROS levels in CSE-WT and -KO SMCs. The 
effect of hypoxic stress on intracellular ROS levels in CSE-WT and -KO SMCs was assessed via 
fluorescent detection of oxidation-induced esterase activity (CM-H2DCFDA assay), and analyzed via flow 
cytometry. Matched passage WT and KO cells were seeded onto 6-well plates, grown overnight to 70-80 
% confluence, and incubated in serum- and antibiotic-free medium in a hypoxia chamber at 1 % O2 for 12 
hours.  The ‘snapshot’ method was utilized, whereby cells were incubated with fluorescent label for 30 
minutes post hypoxic stress in order to ascertain the final redox environment of the cells, and a minimum 
of 1 x 104 gated events were analyzed via flow cytometry. Bars represent mean ± SEM of 3 independent 
experiments. Connected lines indicate relationship; *** denotes significance of p < 0.001. 
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Figure 11. Effect of hypoxic stress on Ψm in CSE-WT and -KO SMCs. The effect of hypoxic stress on 
Ψm in CSE-WT and -KO SMCs was assessed via the fluorescent detection of potential-dependent 
incorporation and conversion of cationic dye (JC-1 assay), and analyzed via flow cytometry. Matched 
passage WT and KO cells were seeded onto 6-well plates, grown overnight to 70-80 % confluence, and 
incubated in serum- and antibiotic-free medium in a hypoxia chamber at 1 % O2 for 12 hours. Cells were 
incubated with fluorescent label for 30 minutes, and a minimum of 1 x 104 gated events were analyzed via 
flow cytometry, wherein the ratio of red to green fluorescence indicated mitochondrial polarization status 
(where increased conversion of the green fluorescent label to red, and thus a higher fluorescence ratio, 
indicated greater depolarization). Bars represent mean ± SEM of 3 independent experiments. Connected 
lines indicate relationship; * denotes significance of p < 0.05; ** denotes significance of p < 0.01. 
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Figure 12. Effect of hypoxic stress on TNF-α mRNA expression in CSE-WT and -KO SMCs. The 
effect of hypoxic stress on TNF-α mRNA expression in CSE-WT and -KO SMCs was assessed via qPCR. 
Matched passage WT and KO cells were seeded onto 75 cm2 tissue culture flasks, grown overnight to 70-
80 % confluence, and incubated in serum- and antibiotic-free medium in a hypoxia chamber at 1 % O2 for 
12 hours. Cells were lysed and their RNA isolated via silica membrane spin column. RNA quantity and 
integrity was assessed via automated electrophoresis. cDNA was generated via oligo-dT-primed reverse 
transcription. Real-time PCR was performed via a two-step cycling program in accordance with the DNA 
polymerase and primer specifications. Results were normalized to β2M and normal expression 
standardized to the normoxic WT condition. Bars represent mean ± SEM of 3 independent experiments. 
Connected lines indicate relationship; *** denotes significance of p < 0.001. 
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Figure 13. Effect of hypoxic stress on IFN-γ mRNA expression in CSE-WT and -KO SMCs. The 
effect of hypoxic stress on IFN-γ mRNA expression in CSE-WT and -KO SMCs was assessed via qPCR. 
Matched passage WT and KO cells were seeded onto 75 cm2 tissue culture flasks, grown overnight to 70-
80 % confluence, and incubated in serum- and antibiotic-free medium in a hypoxia chamber at 1 % O2 for 
12 hours. Cells were lysed and their RNA isolated via silica membrane spin column. RNA quantity and 
integrity was assessed via automated electrophoresis. cDNA was generated via oligo-dT-primed reverse 
transcription. Real-time PCR was performed via a two-step cycling program in accordance with the DNA 
polymerase and primer specifications. Results were normalized to β2M and normal expression 
standardized to the normoxic WT condition. Bars represent mean ± SEM of 3 independent experiments. 
Connected lines indicate relationship; * denotes significance of p < 0.05; *** denotes significance of p < 
0.001. 
 
   
 88 
 
Figure 14. Effect of hypoxic stress on IL-10 mRNA expression in CSE-WT and -KO SMCs. The 
effect of hypoxic stress on IL-10 mRNA expression in CSE-WT and -KO SMCs was assessed via qPCR. 
Matched passage WT and KO cells were seeded onto 75 cm2 tissue culture flasks, grown overnight to 70-
80 % confluence, and incubated in serum- and antibiotic-free medium in a hypoxia chamber at 1 % O2 for 
12 hours. Cells were lysed and their RNA isolated via silica membrane spin column. RNA quantity and 
integrity was assessed via automated electrophoresis. cDNA was generated via oligo-dT-primed reverse 
transcription. Real-time PCR was performed via a two-step cycling program in accordance with the DNA 
polymerase and primer specifications. Results were normalized to β2M and normal expression 
standardized to the normoxic WT condition. Bars represent mean ± SEM of 3 independent experiments. 
Connected lines indicate relationship; * denotes significance of p < 0.05; *** denotes significance of p < 
0.001. 
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Figure 15. Effect of hypoxic stress on TGF-β mRNA expression in CSE-WT and -KO SMCs. The 
effect of hypoxic stress on TGF-β mRNA expression in CSE-WT and -KO SMCs was assessed via qPCR. 
Matched passage WT and KO cells were seeded onto 75 cm2 tissue culture flasks, grown overnight to 70-
80 % confluence, and incubated in serum- and antibiotic-free medium in a hypoxia chamber at 1 % O2 for 
12 hours. Cells were lysed and their RNA isolated via silica membrane spin column. RNA quantity and 
integrity was assessed via automated electrophoresis. cDNA was generated via oligo-dT-primed reverse 
transcription. Real-time PCR was performed via a two-step cycling program in accordance with the DNA 
polymerase and primer specifications. Results were normalized to β2M and normal expression 
standardized to the normoxic WT condition. Bars represent mean ± SEM of 3 independent experiments. 
Connected lines indicate relationship; * denotes significance of p < 0.05; *** denotes significance of p < 
0.001. 
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Figure 16. Effect of hypoxic stress on HIF-1α mRNA expression in CSE-WT and -KO SMCs. The 
effect of hypoxic stress on HIF-1α mRNA expression in CSE-WT and -KO SMCs was assessed via qPCR. 
Matched passage WT and KO cells were seeded onto 75 cm2 tissue culture flasks, grown overnight to 70-
80 % confluence, and incubated in serum- and antibiotic-free medium in a hypoxia chamber at 1 % O2 for 
12 hours. Cells were lysed and their RNA isolated via silica membrane spin column. RNA quantity and 
integrity was assessed via automated electrophoresis. cDNA was generated via oligo-dT-primed reverse 
transcription. Real-time PCR was performed via a two-step cycling program in accordance with the DNA 
polymerase and primer specifications. Results were normalized to β2M and normal expression 
standardized to the normoxic WT condition. Bars represent mean ± SEM of 3 independent experiments. 
Connected lines indicate relationship; * denotes significance of p < 0.05; *** denotes significance of p < 
0.001. 
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Project II - CSE in simulated hypoxia and hypoxia-reoxygenation cardiac stress 
 
Effect of CoCl2 on HL-1 cardiomyocyte viability 
CoCl2 induces so-called ‘simulated’ hypoxia by specifically activating HIF-1-mediated 
transcription, even under normoxic conditions. Following consideration of the available 
literature, and in an effort to reproduce, in part, the CoCl2 stress model of simulated hypoxia 
described previously [257], a variety of concentrations and treatment durations were evaluated 
via colourimetric MTT assay (data not shown), and 24-hour treatment with 200 µM CoCl2 was 
chosen for study. Cell viability was significantly decreased in 200 µM CoCl2-treated HL-1 
cardiomyocytes (-28 %, p < 0.001; Figure 17), which was similar to the extent of change 
previously described by Vassilopoulos et al. in this model [257]. 
 
Effect of CoCl2 on HL-1 cardiomyocyte ROS levels 
Given the observed CoCl2-induced decreases in cardiomyocyte survival, and given that 
ROS elaboration was previously shown to be the major contributory factor to CoCl2-induced HL-
1 cardiomyocyte death [257], cells were subjected to 24 hours of 200 µM CoCl2, and intracellular 
ROS levels were assessed via the fluorescent CM-H2DCFDA assay (using ‘snapshot’ method), 
with analysis via flow cytometry. 200 µM CoCl2 induced significantly increased ROS levels 
(+121 %, p < 0.05; Figure 18). 
 
Effect of CoCl2 on HL-1 cardiomyocyte CSE protein expression 
In order to investigate the potential for changes in CSE expression in response to 
simulated hypoxia, given that the endogenous H2S/CSE pathway had previously been shown to 
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be cardioprotective against ischemic insult [66, 85, 271], HL-1 cardiomyocytes were subjected to 
24 hours of 200 µM CoCl2, and CSE protein expression assessed via immunoblotting, with 
analysis via densitometry. CSE expression was significantly increased in 24-hour, 200 µM 
CoCl2-treated HL-1 cardiomyocytes (+79 %, p < 0.05; Figure 19). 
 
Effect of CSE inhibition on CoCl2-induced decrease in HL-1 cardiomyocyte viability 
Given the observed CoCl2-induced CSE expression, inhibition of CSE via the irreversible 
chemical inhibitor, D,L-propargylglycine (PPG) was undertaken in order to investigate the 
potential contributions of H2S/CSE pathway to cardiomyocyte function under CoCl2 stress. Based 
on the available literature, a 24-hour concentration course of PPG concentrations including 100 
µM, 1 mM, and 10 mM was performed, and cell viability was assessed via the colourimetric 
MTT assay (wherein MTT reagent was added at t = 20 hours). None of the evaluated PPG 
concentrations induced significant change in cell viability from control (Figure 20). As a result, 
the highest PPG concentration, 10 mM, was selected for future experiments; the thinking being 
that it should have the greatest CSE-inhibitory effect. The effect of PPG-mediated CSE inhibition 
in CoCl2-stressed HL-1 cardiomyocytes was investigated via MTT assay, wherein cells were pre-
treated with the previously optimized PPG concentration, 10 mM, and subjected to 200 µM 
CoCl2 as previously described. While CoCl2 significantly reduced cell viability (-27 %, p < 0.01; 
Figure 21) and PPG control had no effect, echoing the existing results (Figure 17 and 20, 
respectively), PPG + CoCl2 resulted in much lower viability versus control (-46 %, p < 0.001; 
Figure 21) than CoCl2 alone. 
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Effect of H-R on HL-1 cardiomyocyte viability 
Following consideration of the available literature, and in an effort to produce conditions 
that would approximate the in vivo situation for cardiomyocytes experiencing I-R injury, HL-1 
cardiomyocytes were subjected to an H-R regimen as follows: 12 hours of hypoxia (1 % O2) 
followed by 4 hours of normoxia (~20 % O2). Cell viability was assessed via the colourimetric 
MTT assay, wherein MTT reagent was added to cultures at t = 12 hours (upon completion of the 
hypoxia phase) and incubated for the remaining duration of the H-R regimen (4 hours normoxia), 
before analysis at t = 16 hours. Cell viability was significantly decreased in H-R-challenged HL-1 
cardiomyocytes (-37 %, p < 0.001; Figure 22). 
 
Effect of H-R on HL-1 cardiomyocyte CSE expression 
Given that the endogenous H2S/CSE pathway had previously been shown to be 
cardioprotective against ischemic insult [66, 85, 271], given our finding that CSE expression was 
increased in response to simulated hypoxia (Figure 19), CSE protein expression was assessed via 
immunoblot in H-R-challenged HL-1 cardiomyocytes, with analysis via densitometry. H-R 
induced significantly increased CSE expression (+94 %, p < 0.05; Figure 23) in the HL-1 
cardiomyocytes, on the order of that observed upon CoCl2 stress (Figure 19). 
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Figure 17. Effect of CoCl2 on HL-1 cardiomyocyte viability. The effect of CoCl2 on HL-1 
cardiomyocyte viability was assessed via colourimetric measurement of mitochondrial dehydrogenase 
activity (MTT assay). Cells were seeded onto 96-well plates, grown overnight to approximately 95 % 
confluence, and in incubated serum- and antibiotic-free medium containing 200 µM CoCl2 for 24 hours.  
MTT reagent was added at t = 20 hours and absorbance was measured spectrophotometrically at 490 nm 
(650 nm correction wavelength) at t = 24 hours. Normal viability was standardized to the unstressed 
control condition. Bars represent mean ± SEM of 3 independent experiments. *** denotes significance of 
p < 0.001. 
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Figure 18. Effect of CoCl2 on intracellular ROS levels in HL-1 cardiomyocytes. The effect of CoCl2 
on intracellular ROS levels in HL-1 cardiomyocytes was assessed via fluorescent detection of oxidation-
induced esterase activity (CM-H2DCFDA assay), and analyzed via flow cytometry. Cells were seeded 
onto 96-well plates, grown overnight to approximately 95 % confluence, and incubated in serum- and 
antibiotic-free medium containing 200 µM CoCl2 for 24 hours.  The ‘snapshot’ method was utilized, 
whereby cells were incubated with fluorescent label for 30 minutes post hypoxic stress in order to 
ascertain the final redox environment of the cells, and a minimum of 1 x 104 gated events were analyzed 
via flow cytometry. Bars represent mean ± SEM of 3 independent experiments. * denotes significance of p 
< 0.05. 
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Figure 19. Effect of CoCl2 on CSE protein expression in HL-1 cardiomyocytes. The effect of CoCl2 on 
CSE protein expression in HL-1 cardiomyocytes was assessed via immunoblotting. Cells were seeded 
onto 75 cm2 tissue culture flasks, grown overnight to approximately 95 % confluence, and incubated in 
serum- and antibiotic-free medium containing 200 µM CoCl2 for 24 hours. Cells were lysed via RIPA 
buffer and their protein levels quantitated via colourimetric, Lowry-based assay. Total proteins were 
separated via SDS-PAGE (verified via Coomassie Blue stain), and transferred electrophoretically to PVDF 
membranes (verified via Ponceau S stain). Membranes were blocked in milk solution and incubated with 
polyclonal primary antibody, then washed repeatedly, incubated with secondary antibody, and washed 
again. Membranes were analyzed via enhanced chemiluminescent detection imager and software-assisted 
densitometry. Bars represent mean ± SEM of 3 independent experiments. * denotes significance of p < 
0.05. 
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Figure 20. Effect of PPG on HL-1 cardiomyocyte viability. The effect of PPG on HL-1 cardiomyocyte 
viability was assessed via colourimetric measurement of mitochondrial dehydrogenase activity (MTT 
assay). Cells were seeded onto 96-well plates, grown overnight to approximately 95 % confluence, and 
incubated in serum- and antibiotic-free medium containing 100 µM, 1 mM and 10 mM PPG for 24 hours.  
MTT reagent was added at t = 20 hours and absorbance was measured spectrophotometrically at 490 nm 
(650 nm correction wavelength) at t = 24 hours. Normal viability was standardized to the unstressed 
control condition. Bars represent mean ± SEM of 3 independent experiments. 
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Figure 21. Effect of PPG pre-treatment on CoCl2-mediated changes in HL-1 cardiomyocyte 
viability. The effect of PPG pre-treatment on CoCl2-mediated changes in HL-1 cardiomyocyte viability 
was assessed via colourimetric measurement of mitochondrial dehydrogenase activity (MTT assay). Cells 
were seeded onto 96-well plates, grown overnight to approximately 95 % confluence, and pre-treated with 
serum- and antibiotic-free medium containing 10 mM PPG for 24 hours prior to incubation in serum- and 
antibiotic-free medium containing 200 µM CoCl2 for 24 hours.  MTT reagent was added at t = 20 hours 
(CoCl2 phase) and absorbance was measured spectrophotometrically at 490 nm (650 nm correction 
wavelength) at t = 24 hours. Normal viability was standardized to the unstressed control condition. Bars 
represent mean ± SEM of 3 independent experiments. Connected lines indicate relationship; * denotes 
significance of p < 0.05; *** denotes significance of p < 0.01; *** denotes significance of p < 0.001. 
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Figure 22. Effect of H-R on HL-1 cardiomyocyte viability. The effect of H-R on HL-1 cardiomyocyte 
viability was assessed via colourimetric measurement of mitochondrial dehydrogenase activity (MTT 
assay). Cells were seeded onto 96-well plates, grown overnight to approximately 95 % confluence, and 
incubated in serum- and antibiotic-free medium for 12 hours of hypoxia at 1 % O2 followed by 4 hours of 
normoxia at ~20 % O2. MTT reagent was added at t = 12 hours and absorbance was measured 
spectrophotometrically at 490 nm (650 nm correction wavelength) at t = 16 hours. Normal viability was 
standardized to the unstressed control condition. Bars represent mean ± SEM of 3 independent 
experiments. *** denotes significance of p < 0.001. 
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Figure 23. Effect of H-R on CSE protein expression in HL-1 cardiomyocytes. The effect of H-R on 
CSE protein expression in HL-1 cardiomyocytes was assessed via immunoblotting. Cells were seeded 
onto 75 cm2 tissue culture flasks, grown overnight to approximately 95 % confluence, and incubated in 
serum- and antibiotic-free medium for 12 hours of hypoxia at 1 % O2 followed by 4 hours of normoxia at 
~20 % O2. Cells were lysed via RIPA buffer and their protein levels quantitated via colourimetric, Lowry-
based assay. Total proteins were separated via SDS-PAGE (verified via Coomassie Blue stain), and 
transferred electrophoretically to PVDF membranes (verified via Ponceau S stain). Membranes were 
blocked in milk solution and incubated with polyclonal primary antibody, then washed repeatedly, 
incubated with secondary antibody, and washed again. Membranes were analyzed via enhanced 
chemiluminescent detection imager and software-assisted densitometry. Bars represent mean ± SEM of 3 
independent experiments. * denotes significance of p < 0.05. 
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Discussion 
 
Project I - Hypoxic stress in CSE-deficient smooth muscle cells 
 
CSE WT and KO vascular SMCs were subjected to hypoxia in order to discern potential 
H2S/CSE pathway-related contributions to the SMC hypoxic stress response. The likelihood of 
differences in the two cell lines was predicated on evidence for an important relationship between 
O2 tension and H2S’s cellular functions [256], as well as essential roles for H2S in hypoxia-related 
vascular diseases such as hypoxic pulmonary hypertension [161, 215-224] and atherosclerosis 
[85, 90, 92, 272-276]. CSE-deficiency had previously been demonstrated to result in hypertension 
and impaired blood pressure regulation in the very mouse model from which the present SMCs 
were derived [99]. Moreover, we previously described markedly enhanced proliferation of CSE 
KO versus WT SMCs under basal conditions that was primary to the observed hypertension in 
vivo, as evidenced by a lack of change in cell proliferation upon CSE KO animal blood pressure 
normalization via captopril [94]. We also found the CSE-deficient SMCs to be more susceptible 
to exogenous H2S-induced apoptosis, which was mediated by phosphorylation of ERK1/2 and 
altered expression of the cell cycle regulators, cyclin D1 and p21(Cip/WAF-1) [94]. This sensitivity of 
endogenous H2S/CSE pathway-inhibited cells to exogenously-applied H2S has previously been 
demonstrated to effectively inhibit SMC proliferation [93, 95], deficiency of which is thought to 
contribute to atherosclerosis [228]. Taken together, these data add considerable weight to the 
concept of a critical role for H2S/CSE pathway in the regulation of vascular homeostasis. 
Given that hypoxia is a ubiquitous feature of the pathogenesis of atherosclerosis and 
hypertension, and given the aforementioned importance of H2S therein, here we endeavoured to 
pursue the hypothesis that CSE-deficient SMCs should exhibit compromised hypoxia stress 
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response and poorer survivability. To this end, we measured cell viability and apoptosis, as well 
as the expression of the master transcriptional regulator of the hypoxic stress response, HIF-1, 
which had recently been implicated in H2S/CSE pathway signaling [300]. Given the important 
contributions of oxidative stress [114, 131] and inflammation [131, 181] to vascular disease, we 
sought also to evaluate differences in CSE WT and KO SMC redox and inflammatory status. 
Finally, due to the recent fervent interest in, and evidence for, the cellular effects of H2S that 
centre on the mitochondrion [102], we compared mitochondrial membrane potential (Ψm) in the 
two SMC lines. We had previously demonstrated that the CSE KO SMCs did not feature 
detectable CSE mRNA or protein, and that their H2S production was only a small fraction of their 
WT counterparts [91]. These investigations were undertaken with the knowledge that no 
published data existed on the SMC response to hypoxia in CSE genetic knockout animals or cell 
models, and were thus timely and relevant to the state of the art. 
Even under basal conditions – that is, 24-hour incubation is serum- and antibiotic-free 
medium, but no specific stressor – stark differences in CSE WT and KO SMCs were observed. 
KO cells featured significantly higher metabolic activity than their WT counterparts, as measured 
by mitochondrial dehydrogenase activity via the MTT assay (Figure 4). This data indicates a 
substantially higher rate of oxidative phosphorylation in the KO cells, suggesting greater ATP 
production and mitochondrial activity therein. The higher relative metabolic activity is consistent 
with our previous finding that (serum-supplemented) KO cells exhibited greater proliferation than 
WT cells [94], in that proliferating SMCs have greater energy requirements that must be met by 
ramped up glycolysis and mitochondrial respiration. 
Commensurate with just such a scenario of increased cellular respiration and/or 
mitochondrial function – and thus increased by-production of ROS – both intracellular ROS 
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levels and Ψm were significantly higher in CSE KO versus WT SMCs (Figures 5 & 6). 
Importantly, these data are consistent with the previously described protective roles for H2S/CSE 
pathway in regulating redox balance [64-71] and suppressing mitochondrial activity [82, 99, 
100]. Indeed, Blackstone & Roth (2007) suggested that the mitochondria-suppressive effect of 
exogenous H2S could be employed therapeutically to protect against hypoxia. They discovered 
that, while mice could not survive longer than 20 minutes at 5 % O2, H2S pre-treatment afforded 
their survival for 6.5 hours, with no apparent detrimental effects [102]. In light of this, then, it is 
perhaps unsurprising that CSE deficiency was presently found to have the opposite effect; 
unbridled cellular metabolism (Figures 4 & 7) and growth [91], with concomitant increases in 
intracellular ROS (Figure 5). Taken together, these findings suggest a compromised ability of 
KO cells to regulate redox levels and/or the by-production of ROS resulting from deficient 
homeostatic H2S-mediated mitochondrial regulation. 
In order to test to the relative responses of CSE WT and KO SMCs to hypoxic stress, cells 
were incubated for 12 hours in a hypoxic chamber set to 1 % O2. While the literature offers many 
and varied in vitro hypoxia regimes, the present protocol was chosen in order to approximate the 
chronic situation typical of the prolonged, attritional pathology of vascular conditions such as 
atherosclerosis and hypertension [228]. While CSE WT cell viability was not significantly 
impacted by hypoxia, KO cell viability was drastically reduced relative to control, as measured 
via MTT assay (Figure 7). Similarly, although both cell lines experienced significant apoptosis 
versus their respective controls, the rate of KO SMC apoptosis was considerably greater than that 
of the WT cells, as evidenced by positive staining for active caspases-3 and -7 measured via flow 
cytometry (Figure 8). Taken together, these data clearly indicate that CSE KO cells were more 
susceptible to hypoxia-induced death than their WT counterparts, suggesting an essential 
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contribution of H2S/CSE pathway to some aspect(s) of the protective hypoxic stress response. 
This is consistent with the previous findings that impaired endogenous H2S/CSE pathway 
contributes to the pathogenesis of hypertension [163, 257-268] and diabetes [277, 278], wherein 
hypoxic stress is an important factor. As well, these data point to the importance of specific 
H2S/CSE levels in exerting a specific homeostatic effect. That is, the present findings indicate 
that deficient H2S/CSE compromises SMC survivability, while other studies have demonstrated 
similarly pro-apoptotic effects resulting from exogenous H2S administration [65, 93, 95, 98, 272] 
and/or CSE over-expression [65, 95, 272]. Given that the extent of the hypoxia-induced changes 
in apoptosis was deemed to be within a reasonable, physiologically relevant range, the present 
hypoxia protocol was retained for subsequent experiments. 
Keenly in step with the concepts that H2S protects against hypoxia in part by regulating 
mitochondrial function [87, 99] via stabilization of its structure [85], and as well as modulation of 
redox balance via direct [65-69] and indirect [64, 65, 68-71] antioxidant effects, an investigation 
of the factors underlying the observed hypoxia-induced SMC apoptosis was undertaken, with 
redox status and Ψm assessed via the colourimetric SOD activity assay and the fluorescent CM-
H2DCFDA and JC-1 assays, respectively. Hypoxia caused identical increases in SOD activity in 
CSE WT and KO cells, revealing enhanced antioxidant capacity in response to the low O2 stress 
that was not visibly affected by H2S/CSE pathway status (Figure 9). Despite this parity, however, 
intracellular ROS levels were significantly increased in hypoxic KO SMCs while unchanged in 
their stressed WT counterparts (Figure 10). Thus, given no differences in antioxidant capacity 
between hypoxic WT and KO cells despite substantially greater ROS elaboration in the latter, a 
pronounced hypoxia-induced redox imbalance was present in the CSE-deficient SMCs. These 
findings are in agreement with the concept that decreased H2S/CSE pathway in the pathogenesis 
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of vascular disease [74, 218, 224, 273-276] contributed to the redox imbalance typical therein 
[114, 131]. Moreover, these findings are consistent with the previous study by Wei et al. (2008), 
where, in hypoxia-stressed lung tissues, H2S increased T-AOC and decreased GSSG, but did not 
affect SOD [74]. Indeed, they noted that, even in the control group, wherein hypoxia caused 
decreased H2S/CSE pathway, no changes in SOD were observed [74], as per our present findings.  
Hypoxic insult of the SMCs also did not significantly affect Ψm in either cell line, but, as 
was the case under basal conditions, the absolute Ψm values remained significantly higher in CSE 
KO versus WT SMCs (Figure 11). Taken together, these data indicate a hypoxic stress-induced 
exaggeration of the redox and Ψm discrepancies between WT and KO cells observed under basal 
conditions, underscoring the substantial impact of CSE-deficiency in SMCs. Moreover, these data 
indicate a pronounced hypoxia-induced redox imbalance that may explain the significantly 
increased apoptosis and decreased viability of hypoxic CSE KO SMCs versus their WT 
counterparts. 
Inflammation is an important contributory factor in atherogenesis [131, 181], and an anti-
inflammatory role for H2S has been demonstrated in several cardiovascular models [86] [277, 
278]. Moreover, a significant relationship exists between oxidative stress and inflammation in 
cardiovascular diseases leading to heart failure, such that increased ROS has been shown to 
promote pro-inflammatory mediator expression [13, 135, 170, 179, 182, 183]. Given this context, 
and the present observation of a pronounced redox imbalance in CSE KO SMCs by virtue of 
hypoxia-induced ROS elaboration, assessment of the mRNA expression of several inflammatory 
mediators – TNF-α, IFN-γ, IL-10 and TGF-β – was undertaken via qPCR, with normalization via 
β2M.  
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Under basal conditions, CSE KO SMCs featured significantly lower expression of TNF-α 
(Figure 12) and IFN-γ (Figure 13), and significantly higher expression of IL-10 (Figure 14) and 
TGF-β (Figure 15) versus their WT counterparts. Taken together, these data indicate that the 
CSE-deficient cells featured inherently perturbed inflammatory mediator expression, as 
evidenced by their substantially lower pro-inflammatory cytokine/chemokine (TNF-α & IFN-γ) 
and massively higher anti-inflammatory cytokine (IL-10 & TGF-β) expression. However, it is 
unclear why this was the case. Indeed, the opposite scenario would be easier to explain, given the 
generally anti-inflammatory role described for H2S [2, 26, 30, 86, 100]. That said, few studies 
have reported on inflammatory mediator expression vis-à-vis endogenous H2S/CSE pathway 
status, so these findings are not necessarily out of step with any established trend. In particular, Li 
et al. (2005) found plasma TNF-α to be increased upon administration of exogenous H2S, as well 
as decreased inflammatory mediator expression upon blockade of endogenous H2S/CSE pathway 
in a mouse model of endotoxin-induced shock [30]. Here, one positive is consistency; both of the 
pro-inflammatory and both of the anti-inflammatory cytokines were decreased and increased, 
respectively, perhaps lending some credence to these observations. However, further experiments 
are certainly warranted, as is cautiousness regarding the interpretation of the present results in the 
interim. 
Interesting, albeit similarly perplexing results were obtained upon 12-hour hypoxic insult 
of the SMC lines. Here, TNF-α expression was significantly decreased in WT but not KO cells 
(Figure 12). IFN-γ expression was decreased in WT but substantially increased in KO cells 
(Figure 13). IL-10 expression was massively increased in WT but substantially decreased in KO 
cells (Figure 14). TGF-β expression was increased in KO cells but massively increased in WT 
cells (Figure 15). Taken together, these data indicate that hypoxic stress elicited a more pro-
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inflammatory environment in the KO cells despite their lower relative inflammatory environment 
versus WT cells under basal conditions, suggesting an altered, CSE-deficiency-related 
inflammatory response to hypoxic stress. We have previously reviewed the importance and 
redox-relevance of inflammatory imbalance – in particular, of high IL-10:TNF-α – in the 
progression to heart failure [13]. Consistent with this concept, here we observed much higher IL-
10:TNF-α in basal KO versus WT cells that diminished greatly upon hypoxic insult. Moreover, 
the observed change toward a more pro-inflammatory intracellular environment in the hypoxic 
CSE KO cells was accompanied by a concomitant change toward a more oxidized intracellular 
environment, as per the SOD (Figure 9) and ROS level (Figure 10) data above. However, 
several specific issues with these findings are additionally noteworthy.  
First, given that an antioxidant effect of IL-10 in cardiovascular tissues has been described 
[13, 174, 182], the observation that its CSE KO SMC expression was much higher than that of 
WT cells under basal conditions (Figure 14) despite higher ROS (Figure 5) is incompatible with 
this concept. That said, given that deficient homeostatic H2S-mediated mitochondrial regulation, 
as evidenced by increased Ψm (Figure 6), was proposed as a potential reason for the increased 
ROS in basal KO cells, and given that it did not significantly change upon hypoxic stress (Figure 
11), it is possible that Ψm-associated ROS production explains these differences. However, this 
interpretation is largely unsupported and highly conjectural, and thus is provided only because 
due analysis is required. Second, the stark decrease in CSE WT SMC TNF-α expression upon 
hypoxia is not supported by the literature, and the near-equivalent TNF-α expression in all other 
conditions (Figure 12) begs the question of artifact. Thus, despite their promise, these findings 
require further validation before any real conclusions should be drawn. Ideally, a well-established 
inflammatory control, such as LPS, should be employed in order to demonstrate clearly that the 
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CSE WT SMCs respond in a manner that can be clearly supported by the literature. Failure to 
provide these assurances undermines any KO cell findings, however interesting and accurate they 
might be. 
The hypoxia stress response is essential to cellular survival in low O2 conditions, which 
are ubiquitous in disease, and play major roles in the pathogenesis of atherosclerosis [129, 131] 
and hypertension [16, 114, 131, 241]. HIF-1 is recognized as a critical mediator of the response to 
hypoxia, activating over 200 genes encoding proteins that regulate cellular metabolism, 
proliferation, survival, motility and basement membrane integrity, as well as angiogenesis and 
hematopoiesis [185, 238, 242]. Given the patently poorer ability of the CSE-deficient SMCs to 
respond to hypoxic stress, and in light of new research suggesting an important interaction of H2S 
and HIF-1 [255] and potential role in O2 sensing [256], an assessment of the mRNA expression 
of HIF-1’s O2-sensitive alpha subunit, HIF-1α, was undertaken via qPCR, with normalization via 
β2M. 12-hour hypoxia induced increased HIF-1α expression in CSE KO SMCs, but a 
significantly greater increase in HIF-1α expression in WT cells (Figure 16). These data indicate a 
H2S/CSE pathway-related impact on HIF-1α expression, which may have contributed to the 
inability of KO cells to respond to hypoxic stress as effectively as their WT counterparts, as 
evidenced by redox (Figures 9 & 10) and inflammatory (Figures 12-15) imbalance, and 
decreased survival (Figures 7 & 8). 
Budde & Roth (2010) discovered that hif-1 was required for Caenorhabditis elegans 
survival upon H2S exposure, and that elevated HIF-1 activity dramatically increased the 
maximum tolerable concentration of H2S. They also demonstrated that both H2S and hypoxia 
induced HIF-1 protein expression, but in different tissue patterns [255]. These findings are 
consistent with the present data indicating that hypoxic CSE KO SMCs feature blunted HIF-1α 
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mRNA expression versus their WT counterparts (Figure 16). That is, if endogenous H2S is 
greatly reduced (we observed ~7 % H2S production in the CSE KO cells [91]), and H2S acts as a 
regulator of hif-1 by virtue of cells’ requiring its expression to deal with H2S [255], then HIF-1α 
is likely also to be reduced in H2S/CSE pathway-deficient cells. However, no discernable 
difference was evident under basal conditions, as hypoxia was required to reveal a significant 
difference in HIF-1α expression between the CSE WT and KO SMCs (Figure 16).  
Taken together, the results of these experiments indicate that CSE-deficiency predisposes 
SMCs to decreased survivability upon hypoxic insult. The hypoxia-induced decrease in CSE KO 
cell viability (Figure 7) and increase in apoptosis (Figure 8) was associated with significant 
elaboration of intracellular ROS (Figure 10), pro-inflammatory climate (Figure 12-15) and 
compromised HIF-1α expression (Figure 16). The latter finding begs the questions of whether 
deficient H2S directly or indirectly caused decreased HIF-1α, which in turn led to a generally 
poorer hypoxia stress response, or whether KO cells were more susceptible to hypoxia because 
the HIF-1-mediated stress response involves H2S/CSE pathway function. The latter possibility is 
encouraged by the present finding that the hypoxia mimetic, CoCl2, which is known to activate 
HIF-1 via stabilization of its O2-sensitive alpha subunit, induced increased CSE protein 
expression in HL-1 cardiomyocytes (Figure 19; discussed below). Regardless, both potential 
situations are remarkable, as they would represent new knowledge and novel downstream targets 
of HIF-1 and/or H2S. Indeed, whatever the ‘chicken or egg’ relationship between H2S and HIF-1, 
it is clear that H2S is essential to the SMC response to hypoxia. Such discoveries would surely 
find purchase in many areas, including H2S’s role in hypoxic pulmonary hypertension, 
atherosclerosis and O2-sensing, as well as the myriad processes wherein HIF-1 is already 
implicated, such as cancer biology [279] and immune function [280]. Moreover, the present 
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findings provide a possible link between the phenomena of endogenous H2S-mediated protection 
against hypoxia [102], haemorrhage [281] and I-R injury [85], as well as hypoxic and sulfide pre- 
[64, 190] and post-conditioning [191, 197], and O2-sensing [36]. 
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Project II - CSE in simulated hypoxia and hypoxia-reoxygenation cardiac stress 
 
Hypoxia is a ubiquitous feature of pathologies including myocardial ischemia, stroke, 
inflammation and cancer [238]. By limiting O2 availability for the electron transport chain and/or 
inhibiting its activity, hypoxia enhances electron leak, leading to oxidative stress. By virtue of 
their continuous exposure to ROS, mitochondria accumulate oxidative damage rapidly, and their 
dysfunction has been identified in many studies of ROS-induced cell death [257]. Increasing 
evidence indicates that hypoxia-induced ROS play a key role in promoting cytochrome c release 
in the mitochondria, leading to apoptosis [308, [282]. A cardioprotective role for H2S has been 
described, and, in addition to its antioxidant [67-74] and anti-inflammatory [82, 84-87] effects, an 
important aspect of its cytoprotection appears to be stabilization of mitochondrial structure and 
function [85]. Indeed, in multiple models, H2S has been shown to suppress metabolic activity via 
inhibition of cytochrome c release [102, 103], leading to the proposal for therapies based on this 
function [102]. Thus, H2S is an attractive candidate for combating hypoxic stress, lending to the 
increasingly clear importance of its homeostatic role in the cardiovascular system, wherein it has 
been implicated in a variety of processes including ischemic pre- [50, 247-253] and post-
conditioning [255-256], pulmonary hypertension [161, 215-224] and atherosclerosis [288-292]. 
However, the specifics of hypoxic regulation of H2S/CSE pathway remain largely unexplored, 
and progress in old and new avenues of H2S research alike, such as its newly proposed role in O2 
sensing [104], will depend heavily on an improved understanding of these processes. 
To deal with hypoxic stress, cells employ adaptive mechanisms including activation of 
genes essential for cell survival, a process that is generally mediated by hypoxia inducible factor-
1 (HIF-1), a transcriptional complex that binds to the specific hypoxia response element of target 
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genes [241]. A heterodimer, HIF-1 is composed of the rate limiting factor, Hif-1α, and the 
constitutively expressed Hif-1β (also called the aryl hydrocarbon receptor nuclear translocator). 
Hif-1α is expressed during normoxia, but is unstable due to constant rapid, proteasome-mediated 
degradation via ubiqitination of the hydroxylated, O2-dependent degradation domain of the α-
subunit by the product of the Von Hippel Lindau (VHL) tumor suppressor gene. Under hypoxic 
conditions, however, the VHL protein cannot recognize Hif-1a, leading to HIF-1 accumulation 
[289, 308]. In the ischemic myocardium, for example, HIF-1 mediates the transcription of the 
vascular endothelial growth factor (VEGF), adrenomedullin, ET-1 and atrial natriuretic peptide 
and other stress-responsive genes [308]. Uniquely, cobalt chloride (CoCl2) acts as a hypoxia 
mimetic via stabilization of HIF-1 via inhibition of the Hif-1α-inhibiting prolyl hydroxylases, 
thereby inducing HIF-1’s downstream genetic program [283, 284]. 
Vassilopoulos et al. (2005) employed CoCl2 to activate HIF-1 and simulate hypoxia in the 
cardiomyocyte cell line, HL-1. Briefly, they found that CoCl2 caused ROS elaboration, leading to 
decreased cardiomyocyte viability. Implicit in this process was ATP depletion, mPTP opening, 
Bax translocation to the mitochondria and cytochrome c release. They also discovered that 
prolonged and/or severe simulated hypoxia caused destabilization of Hif-1α. The CoCl2-induced 
mitochondrial changes leading to decreased cell survival, as well as Hif-1α destabilization were 
attenuated by pre-treatment with various antioxidants, indicating that ROS was the principal 
mechanism of CoCl2’s effect [308]. Given the similarity of CoCl2-induced simulated hypoxia to 
the hypoxia-induced processes in the ischemic myocardium [13, 226], the specificity of CoCl2 for 
HIF-1 activation [283, 284], and the previously described role for H2S/CSE pathway in hypoxic 
conditions (REF), here we endeavoured to explore the potential involvement of H2S/CSE 
pathway in CoCl2-induced simulated hypoxia in HL-1 cardiomyocytes. 
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The mouse atrial cardiomyocyte cell line, HL-1, is an excellent choice for in vitro 
modelng of ischemic damage because it retains its differentiated phenotype indefinitely [259, 
260], and I-R injury only ever occurs in mature cardiomyocytes [13]. Moreover, given that 
Vassilopoulos et al. (2005) used this very cell line for their own CoCl2 studies [308], ready 
validation vis-à-vis the literature was possible. In an effort to reproduce, in part, their simulated 
hypoxia model, a variety of CoCl2 concentrations and treatment durations were evaluated via 
colourimetric MTT assay (data not shown). Of these, the 24-hour treatment with 200 µM CoCl2 
was chosen for continued study. HL-1 cardiomyocyte viability was significantly decreased under 
these conditions (Figure 17), and to a very similar extent as previously reported by Vassilopoulos 
et al. [257]. As ROS elaboration had previously been shown to underlie decreased HL-1 cell 
viability, intracellular ROS level was assessed via the fluorescent CM-H2DCFDA assay (using 
‘snapshot’ method), with analysis via flow cytometry. 24 hours of 200 µM CoCl2 induced 
significantly increased ROS elaboration in the HL-1 cardiomyocytes (Figure 18), thereby 
agreeing with the previously described finding that ROS elaboration was the principal mechanism 
for decreased HL-1 viability [257]. As Vassilopoulos et al. (2005) did not actually measure ROS 
production in their studies, but rather used antioxidant pre-treatment to obtain their findings, the 
present data was deemed to be a sufficient basic recreation of the previous model, and similar use 
of antioxidants was not undertaken.  
Given that the endogenous H2S/CSE pathway had previously been shown to be 
cardioprotective against ischemic insult [66, 85, 271], and in an effort to implicate its activity 
downstream of the HIF-1-mediated signaling cascade, HL-1 cardiomyocytes were subjected to 24 
hours of 200 µM CoCl2, and CSE protein expression assessed via immunoblotting, with analysis 
via densitometry. CSE expression was significantly increased (Figure 19), indicating that 
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H2S/CSE pathway is increased upon CoCl2-induced HIF-1 activation. These data suggest that 
CSE may be a novel downstream target of HIF-1 and/or that H2S/CSE pathway may be involved 
in the hypoxic stress response. Moreover, these findings are consistent with the widely supported 
cardioprotective role for H2S/CSE pathway, and could inform the recent evidence for an O2-
sensing role for H2S [36], as well as the recent evidence for H2S/HIF-1 interaction in C. elegans 
[255].  
Given the observed CoCl2-induced CSE expression, inhibition of CSE via the irreversible 
chemical inhibitor, PPG was undertaken in order to investigate the potential contributions of 
H2S/CSE pathway to cardiomyocyte function upon CoCl2 stress. Based on the available literature, 
a 24-hour concentration course of PPG concentrations including 100 µM, 1 mM and 10 mM was 
performed, and cell viability was assessed via the colourimetric MTT assay (wherein MTT 
reagent was added at t = 20 hours). None of the evaluated PPG concentrations induced significant 
change in cell viability from control (Figure 20). As a result, the highest PPG concentration, 10 
mM, was selected for future experiments; the thinking being that it should have the greatest CSE-
inhibitory effect. A variety of PPG concentrations have been used in different in vitro models, 
ranging from 200 µM [48] to 1-5 mM [47, 53, 285] to 10 mM [285]. In the latter study, while no 
detrimental effects of 10 mM PPG were reported, it did cause increased HO-1 expression in 
aortic SMCs at 12 hours, and increased carboxyhemoglobin levels at 18 hours [334]. This raises 
the possibility that CO/HO-1 pathway could have impacted the HL-1 cardiomyocytes in the 
presently described experiments. A recent study observed CO to increase HIF-1α and VEGF-β 
expression in cardiomyocytes [286]; theoretically, this would have little effect in a model 
whereby HIF-1α is already activated, and by a very specific and potent inducer, CoCl2. However, 
ischemic insult has been shown increase CO/HO-1 pathway cardiac tissues [287], and hypoxia-
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inducible CO has been shown to have cardioprotective effects that include an antioxidant element 
[288, 289]. Thus, as CO/HO-1 pathway was not evaluated in the following experiments, the 
possibility of their involvement via PPG-mediated inducement cannot be discounted. 
The effect of PPG-mediated CSE inhibition in CoCl2-stressed HL-1 cardiomyocytes was 
investigated via MTT assay, wherein cells were pre-treated with the previously optimized PPG 
concentration, 10 mM, and subjected to 200 µM CoCl2 as previously described. While CoCl2 
significantly reduced cell viability (Figure 21) and PPG control had no effect, echoing the 
existing results (Figure 17 and 20, respectively), PPG + CoCl2 resulted in much lower viability 
versus control (Figure 21) than CoCl2 alone. These data indicate that PPG pre-treatment of 
CoCl2-stressed cardiomyocytes was significantly detrimental to cardiomyocyte survival versus 
the stressor alone, strongly indicating a protective contribution of endogenous H2S/CSE pathway 
and/or an essential stress-responsive role. 
Taken together, these data suggest that H2S/CSE pathway is stimulated downstream of 
HIF-1, and that endogenous H2S/CSE pathway has an essential, cardioprotective role in 
abrogating (simulated) hypoxia-induced damage. The present data also lend credence to the novel 
findings of Budde & Roth (2010), who discovered that hif-1 was required for C. elegans survival 
upon H2S exposure, and that elevated HIF-1 activity dramatically increased the maximum 
tolerable concentration of H2S [305]. Here, Budde & Roth found that H2S induced HIF-1, which 
is consistent with our present data from the CSE WT and KO SMC model, wherein blunted HIF-
1α expression was present upon hypoxic insult (Figure 16). It is important to note that the 
present proposal – that CSE is a novel downstream target of HIF-1 – is distinct from these 
findings, and, if verified, would represent new knowledge. Indeed, given the recent revelations 
regarding H2S’s integral relationship with O2 homeostasis [256], the meta-concept of inter-
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regulation between H2S and HIF-1 is plausible, and certainly worthy of directed study. As 
mentioned above, whatever the ‘chicken or egg’ relationship between H2S and HIF-1, it is clear 
that H2S is essential to both the SMC and cardiomyocyte responses to hypoxia. One point of 
caution in moving forward in this avenue of investigation is that both H2S and HIF-1 are widely 
influenced, and influential, and careful reductionist control would therefore need to be exercised. 
 I-R injury is a major complicating feature of clinical disease entities including MI and 
stroke [2, 13]. A cardioprotective role for endogenous H2S/CSE pathway has been demonstrated 
[85], but few in vitro studies exist, leaving much yet to be explained. Given the present 
observation of simulated hypoxia-induced CSE protein expression, we endeavoured to investigate 
whether H-R stress would have a similar effect. Thus, following consideration of the available 
literature, and in an effort to produce conditions that would approximate the in vivo situation for 
cardiomyocytes experiencing I-R injury, HL-1 cardiomyocytes were subjected to an H-R regimen 
as follows: 12 hours of hypoxia (1 % O2) followed by 4 hours of normoxia (~20 % O2). Cell 
viability was assessed via the colourimetric MTT assay, wherein MTT reagent was added to 
cultures at t = 12 hours (upon completion of the hypoxia phase) and incubated for the remaining 
duration of the H-R regimen (4 hours normoxia), before analysis at t = 16 hours. Cell viability 
was significantly decreased in H-R-challenged HL-1 cardiomyocytes (Figure 22). These data 
indicate that HL-1 cardiomyocytes were significantly susceptible to H-R stress; thus was the 
present H-R protocol retained for subsequent experiments. CSE protein expression was assessed 
via immunoblot in H-R-challenged HL-1 cardiomyocytes, with analysis via densitometry. H-R 
induced significantly increased CSE expression (Figure 23) in the HL-1 cardiomyocytes, on the 
order of that observed under CoCl2 stress (Figure 19). Indeed, taken together with the observed 
increase in CSE expression in response to CoCl2-mediated HIF-1 activation, these data 
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collectively indicate that simulated and true hypoxia alike induce H2S/CSE pathway activation, 
possibly downstream of HIF-1-mediated signaling, and are thus consistent with the concept of a 
cardioprotective role for H2S/CSE pathway. 
 There are a number of limitations to this study that must be acknowledged. First, H2S 
proper was not measured directly. Instead, the H2S-synthesizing enzyme, CSE, was used as a 
proxy for H2S/CSE pathway. Indeed, CSE was measured and its endogenous activity altered (via 
chemical inhibition and genetic knockdown), but no specific reconciliation of CSE and cellular 
H2S levels are provided here in support of these findings. That said, in the case of the genetic 
CSE knockout model, we had already shown that the CSE-deficient SMCs featured no detectable 
CSE protein or mRNA expression, and that H2S levels were very low (~7 % versus WT) [94]. It 
was due to these recent data, as well as the project time constraints, that these experiments were 
not repeated. However, as a result it is not possible to say for certain that a given change in CSE 
expression correlated with a similar change in H2S level. Here we use the term “H2S/CSE 
pathway” in the context of WT versus KO SMCs, chemically inhibited CSE (via PPG) and CSE 
protein expression data. 
 Second, cellular metabolism was measured via mitochondrial dehydrogenase activity 
(MTT assay). This assay is typically used to measure decreases in cell viability upon some 
intervention. However, although atypical, the test principle is suitable for the type of 
interpretation presented here. That said, the strength of these interpretations would be greatly 
enhanced by another, sufficiently different cellular metabolism readout, such as ATP 
measurement. Finally, the use of exogenous H2S, administered via an H2S donor compound such 
as sodium hydrosulfide [212], would provide some proof-of-concept support for the present data. 
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Conclusions 
A rapidly growing body of evidence links H2S with NO and CO as the third 
endogenously-produced gaseous signaling transmitter, or gasotransmitter. Reports of its 
physiopharmacological effects indicate its ubiquitous presence throughout mammalian tissues, 
where it has been shown to exert many and varied effects. H2S, which is generated enzymatically 
by the enzyme, CSE, is a critical regulator of cardiovascular homeostasis, with essential roles in 
maintenance of vascular tone, pre- and post-conditioning and cardioprotection against ischemia-
reperfusion injury, as well as inhibition of pathological processes underlying hypertension, 
atherosclerosis and diabetes. Hypoxia is a common feature of normal and disease processes alike, 
and the relevance of H2S to O2 homeostasis is increasingly relevant by virtue of the recent 
evidence for its role in O2-sensing and interaction with the master transcriptional regulator of the 
hypoxia stress repsonse, HIF-1. The results of these in vitro studies demonstrated that CSE-
deficient smooth muscle cells were significantly more susceptible to hypoxic stress than their 
normal counterparts, as evidenced by redox and inflammatory imbalance, and heightened 
mitochondrial activity and cell metabolism. As per their blunted HIF-1 expression upon hypoxic 
insult, deficient hypoxia stress response may have been the underlying cause of the observed 
susceptibility. Moreover, in models of cobalt-induced, simulated hypoxia, as well as hypoxia-
reoxygenation, adult cardiomyocytes exhibited increased CSE expression; inhibition of which 
caused decreased cell viability. Taken together, these findings suggest an essential role for 
H2S/CSE pathway in the hypoxia stress reponse, and indicate the potential involvement of HIF-1 
in their hypoxic regulation. Further study is warranted, and, if validated, these findings may 
represent novel, highly relevant knowledge of H2S’s function in hypoxia and HIF-1-mediated 
processes in cardiovascular tissues. 
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